49 results on '"Jurak, I."'
Search Results
2. Differences in knee skin temperature between left and right leg after running on a treadmill measured by infrared thermography
- Author
-
Svaic, V., primary and Jurak, I., additional
- Published
- 2020
- Full Text
- View/download PDF
3. A systematic review of effective preoperative and postoperative interventions for recovery after hip or knee fracture surgery
- Author
-
Daraboš, N., primary, Medved, S., additional, Jurak, I., additional, Kogler, J., additional, Žura, N., additional, Skočić Hanžek, M., additional, Kovačević, J., additional, Prtorić, A., additional, Radovan, L., additional, Ehrenfreund, T., additional, Kalebota, N., additional, Krnjić, A., additional, Jurišković, M., additional, Zilinski Vrban, R., additional, and Lulić, A., additional
- Published
- 2019
- Full Text
- View/download PDF
4. Measuring centre of gravity and postural shifts in first year primary school students encumbered with a schoolbag
- Author
-
Jurak, I., primary, Rađenović, O., additional, and Bartolac, A., additional
- Published
- 2015
- Full Text
- View/download PDF
5. Molecular-genetic analysis of beta myosin heavy chain gene (MYH7) in Croatian patients with hypertrophic cardiomyopathy
- Author
-
Jelušić, Marija, Malčić, Ivan, Jurak, I, Miličić, D, Pavelić, Krešimir, and Gall-Trošelj, Koraljka
- Subjects
hypertrophic cardiomyopathy ,beta-myosin heavy chain gene ,mutation - Abstract
Hypertrophic cardiomiopathy (HCM) is a genetically and clinically heterogeneous myocardial disease that is, in most of cases, familial and transmitted in a dominant fashion. More than 150 different mutations in 10 genes have been described. The most frequently affected gene, MYH 7, codes beta-myosin heavy chain and was analysed in two groups of patients. The first (I) group consisted of 6 patients (3 females and 3 males, median age at the time of diagnosis 10.8 years) with positive family history. The second (II) group also consisted of 6 patients (2 females and 4 males, median age at the time of diagnosis 9.6 years) with no positive family history. Mutation analysis was carried out for exons 8, 9, 13, 15, 16, 19, 20 and 23 on DNA extracted from the whole blood samples. Fourty mutations have been analysed in these regions (37 substitutions, 2 deletions and 1 insertion). The methods used in this study were mutation specific restriction enzyme assays and DNA sequencing. No mutation has been found. On the basis of these results we can conclude that, in Croatian population, mutations in MYH 7 do not contribute to HCM frequentely.
- Published
- 2004
6. Helicobacter pylori is more frequently associated with atropic than with simple glossitis
- Author
-
Mravak-Stipetić, M, Jurak, I, Ragland, W.L, Pavelić, J, Gall-Trošelj, K, and Pavelić, K.
- Subjects
H.pylori ,oral cavity ,nested PCR ,atrophic glossitis ,glossitis ,mental disorders ,bacterial infections and mycoses ,psychological phenomena and processes - Abstract
Relatoinship between the presence of Helicobacter pylory and different symptoms and diseases in the oral cavity was investigated. Atrophic glossitis was positive for H. pylori in 17 of 87 cases and glossitis was positive in only 1 of 37 cases.
- Published
- 2000
7. <em>Helicobacter pylori</em> colonization of tongue mucosa - increased incidence in atrophic glossitis and burning mouth syndrome (BMS).
- Author
-
Gali-Troëelj, K., Mravak-Stlpetlã, M., Jurak, I., Ragland, W. L., and Paveliô, J.
- Subjects
MUCOUS membranes ,POLYMERASE chain reaction ,HELICOBACTER ,SYMPTOMS ,ORAL mucosa ,ORAL diseases - Abstract
Nested polymerase chain reaction (PCR) was performed to detect the presence of Helicobacter pylon in tongue mucosa in 268 patients divided into four groups according to their diagnosis: 87 with atrophic glossitis, 37 with benign migratory glossitis and 144 with burning mouth syndrome (BMS). The tatter group was subdivided according to anatomic site of burning sensation: subgroup A (54 patients) with complaints limited to tongue and subgroup B (90 patients) with burning sensations in other parts of oral mucosa. H. pylon was found in 43 samples (16%}. Bacteria were significantly less present in tongue mucosa affected with benign migratory glossitis compared with atrophic glossitis and BMS (P-0.025). This difference was more obvious when compared with atrophic glossitis only (P= 0.006). Mucosal changes in these conditions might make the oral environment more acceptable tar H. pylon colonization compared with normal mucosa, and this mechanism may play a role in its oro-oral transmission. [ABSTRACT FROM AUTHOR]
- Published
- 2001
8. Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020
- Author
-
Alm E., Broberg E.K., Connor T., Hodcroft E.B., Komissarov A.B., Maurer-Stroh S., Melidou A., Neher R.A., O'Toole A., Pereyaslov D., Beerenwinkel N., Posada-Cespedes S., Jablonski K.P., Ferreira P.F., Topolsky I., Avsic-Zupanc T., Korva M., Poljak M., Zakotnik S., Zorec T.M., Bragstad K., Hungnes O., Stene-Johansen K., Reusken C., Meijer A., Vennema H., Ruiz-Roldan L., Bracho M.A., Garcia-Gonzalez N., Chiner-Oms A., Cancino-Munoz I., Comas I., Goig G.A., Torres-Puente M., Lopez M.G., Martinez-Priego L., D'Auria G., Ruiz-Hueso P., Ferrus-Abad L., de Marco G., Galan-Vendrell I., Carbo-Ramirez S., Ruiz-Rodriguez P., Coscolla M., Polackova K., Kramna L., Cinek O., Richter J., Krashias G., Tryfonos C., Bashiardes S., Koptides D., Christodoulou C., Bartolini B., Gruber C.E., Di Caro A., Castilletti C., Stefani F., Rimoldi S.G., Romeri F., Salerno F., Polesello S., Nagy A., Jirincova H., Vecerova J., Novakova L., Cordey S., Murtskhvaladze M., Kotaria N., Schar T., Beisel C., Vugrek O., Rokic F., Trgovec-Greif L., Jurak I., Rukavina T., Sucic N., Schonning K., Karst S.M., Kirkegaard R.H., Michaelsen T.Y., Sorensen E.A., Knutson S., Brandt J., Le-Quy V., Sorensen T., Petersen C., Pedersen M.S., Larsen S.L., Skov M.N., Rasmussen M., Fonager J., Fomsgaard A., Maksyutov R.A., Gavrilova E.V., Pyankov O.V., Bodnev S.A., Tregubchak T.V., Shvalov A.N., Antonets D.V., Resende P.C., Goya S., Perrin A., Lee R.T., Yadahalli S., Han A.X., Russell C.A., Schmutz S., Zaheri M., Kufner V., Huber M., Trkola A., Antwerpen M., Walter M.C., van der Werf S., Gambaro F., Behillil S., Enouf V., Donati F., Ustinova M., Rovite V., Klovins J., Savicka O., Wienecke-Baldacchino A.K., Ragimbeau C., Fournier G., Mossong J., Aberle S.W., Haukland M., Enkirch T., Advani A., Karlberg M.L., Lindsjo O.K., Broddesson S., Slavikova M., Lickova M., Klempa B., Staronova E., Ticha E., Szemes T., Rusnakova D., Stadler T., Quer J., Anton A., Andres C., Pinana M., Garcia-Cehic D., Pumarola T., Izopet J., Gioula G., Exindari M., Papa A., Chatzidimitriou D., Metallidis S., Pappa S., Macek M., Geryk J., Broz P., Briksi A., Hubacek P., Drevinek P., Zajac M., Kvapil P., Holub M., Kvapilova K., Novotny A., Kasny M., Klempt P., Vapalahti O., Smura T., Sironen T., Selhorst P., Anthony C., Arien K., Simon-Loriere E., Rabalski L., Bienkowska-Szewczyk K., Borges V., Isidro J., Gomes J.P., Guiomar R., Pechirra P., Costa I., Duarte S., Vieira L., Pyrc K., Zuckerman N.S., Turdikulova S., Abdullaev A., Dalimova D., Abdurakhimov A., Tagliabracci A., Alessandrini F., Melchionda F., Onofri V., Turchi C., Bagnarelli P., Menzo S., Caucci S., Di Sante L., Popa A., Genger J.-W., Agerer B., Lercher A., Endler L., Smyth M., Penz T., Schuster M., Senekowitsch M., Laine J., Bock C., Bergthaler A., Shevtsov A., Kalendar R., Ramanculov Y., Graf A., Muenchhoff M., Keppler O.T., Krebs S., Blum H., Marcello A., Licastro D., D'Agaro P., Laubscher F., Vidanovic D., Tesovic B., Volkening J., Clementi N., Mancini N., Rupnik M., Mahnic A., Walker A., Houwaart T., Wienemann T., Vasconcelos M.K., Strelow D., Jensen B.-E.O., Senff T., Hulse L., Adams O., Andree M., Hauka S., Feldt T., Keitel V., Kindgen-Milles D., Timm J., Pfeffer K., Dilthey A.T., Moore C., Ozdarendeli A., Pavel S.T.I., Yetiskin H., Aydin G., Holyavkin C., Uygut M.A., Cevik C., Shchetinin A., Gushchin V., Dinler-Doganay G., Doganay L., Kizilboga-Akgun T., Karacan I., Pancer K., Maes P., Marti-Carreras J., Wawina-Bokalanga T., Vanmechelen B., Thurmer A., Wedde M., Durrwald R., von Kleist M., Drechsel O., Wolff T., Fuchs S., Kmiecinski R., Michel J., Nitsche A., Casas I., Caballero M.I., Zaballos A., Jimenez P., Jimenez M., Fernandez S.M., Fernandez S.V., de la Plaza I.C., Fadeev A., Ivanova A., Sergeeva M., Stefanelli P., Estee Torok M., Hall G., da Silva Filipe A., Turtle L., Afifi S., McCluggage K., Beer R., Ledesma J., Maksimovic J., Spellman K., Hamilton W.L., Marchbank A., Southgate J.A., Underwood A., Taylor B., Yeats C., Abudahab K., Gemmell M.R., Eccles R., Lucaci A., Nelson C.A., Rainbow L., Whitehead M., Gregory R., Haldenby S., Paterson S., Hughes M.A., Curran M.D., Baker D., Tucker R., Green L.R., Feltwell T., Halstead F.D., Wyles M., Jahun A.S., Ahmad S.S.Y., Georgana I., Goodfellow I., Yakovleva A., Meredith L.W., Gavriil A., Awan A.R., Fisher C., Edgeworth J., Lynch J., Moore N., Williams R., Kidd S.P., Cortes N., Brunker K., McCrone J.T., Quick J., Duckworth N., Walsh S., Sloan T., Ludden C., George R.P., Eltringham G., Brown J.R., Aranday-Cortes E., Shepherd J.G., Hughes J., Li K.K., Williams T.C., Johnson N., Jesudason N., Mair D., Thomson E., Shah R., Parr Y.A., Carmichael S., Robertson D.L., Nomikou K., Broos A., Niebel M., Smollett K., Tong L., Miah S., Wittner A., Phillips N., Payne B., Dewar R., Holmes A., Bolt F., Price J.R., Mookerjee S., Sethi D.K., Potter W., Stanley R., Prakash R., Dervisevic S., Graham J.C., Nelson A., Smith D., Young G.R., Yew W.C., Todd J.A., Trebes A., Andersson M., Bull M., Watkins J., Birchley A., Gatica-Wilcox B., Gilbert L., Kumziene-Summerhayes S., Rey S., Chauhan A., Butcher E., Bicknell K., Elliott S., Glaysher S., Lackenby A., Bibby D., Platt S., Mohamed H., Machin N.W., Mbisa J.L., Evans J., Perry M., Pacchiarini N., Corden S., Adams A.G., Gaskin A., Coombs J., Graham L.J., Cottrell S., Morgan M., Gifford L., Kolyva A., Rudder S.J., Trotter A.J., Mather A.E., Aydin A., Page A.J., Kay G.L., de Oliveira Martins L., Yasir M., Alikhan N.-F., Thomson N.M., Gilroy R., Kingsley R.A., O'Grady J., Gutierrez A.V., Diaz M., Viet T.L., Tedim A.P., Adriaenssens E.M., Patrick Mcclure C., Sang F., Clark G., Howson-Wells H.C., Debebe J., Ball J., Chappell J., Khakh M., Carlile M., Loose M., Lister M.M., Holmes N., Tsoleridis T., Fleming V.M., Wright V., Smith W., Gallagher M.D., Parker M., Partridge D.G., Evans C., Baker P., Essex S., Liggett S., Keeley A.J., Bashton M., Rooke S., Dervisavic S., Meader E.J., Lopez C.E.B., Angyal A., Kristiansen M., Tutill H.J., Findlay J., Mestek-Boukhibar L., Forrest L., Dyal P., Williams R.J., Panchbhaya Y., Williams C.A., Roy S., Pandey S., Stockton J., Loman N.J., Poplawski R., Nicholls S., Rowe W.P.M., Khokhar F., Pinckert M.L., Hosmillo M., Chaudhry Y., Caller L.G., Davidson R.K., Griffith L., Rambaut A., Jackson B., Colquhoun R., Hill V., Nichols J., Asamaphan P., Darby A., Jackson K.A., Iturriza-Gomara M., Vamos E.E., Green A., Aanensen D., Bonsall D., Buck D., Macintyre-Cockett G., de Cesare M., Pybus O., Golubchik T., Scarlett G., Loveson K.F., Robson S.C., Beckett A., Lindsey B., Groves D.C., Parsons P.J., McHugh M.P., Barnes J.D., Manso C.F., Grammatopoulos D., Menger K.E., Harrison E., Gunson R., Peacock S.J., Gonzalez G., Carr M., Mihaela L., Popovici O., Brytting M., Bresner C., Fuller W., Workman T., Mentis A.F., Kossyvakis A., Karamitros T., Pogka V., Kalliaropoulos A., Horefti E., Kontou A., Martinez-Gonzalez B., Labropoulou V., Voulgari-Kokota A., Evangelidou M., Bizta P., Belimezi M., Lambrechts L., Doymaz M.Z., Yazici M.K., Cetin N.S., Karaaslan E., Kallio-Kokko H., Virtanen J., Suvanto M., Nguyen P.T., Ellonen P., Hannula S., Kangas H., Sreenu V.B., Burian K., Terhes G., Gombos K., Gyenesei A., Urban P., Herczeg R., Jakab F., Kemenesi G., Toth G.E., Somogyi B., Zana B., Zeghbib S., Kuczmog A., Foldes F., Lanszki Z., Madai M., Papp H., Pereszlenyi C.I., Babinszky G.C., Dudas G., Csoma E., Abou Tayoun A.N., Alsheikh-Ali A.A., Loney T., Nowotny N., Abdul-Wahab O., Gonzalez-Candelas F., Andersen M.H., Taylor S., MARTI CARRERAS, Joan, Vanmechelen, Bert, Wawina, Tony, Medical Microbiology and Infection Prevention, AII - Infectious diseases, WHO European Region Sequencing Lab, GISAID EpiCoV Grp, Erik, Alm, Eeva K, Broberg, Thomas, Connor, Emma B, Hodcroft, Andrey B, Komissarov, Sebastian, Maurer-Stroh, Angeliki, Melidou, Richard A, Neher, Áine, O’Toole, Dmitriy, Pereyaslov, WHO European Region sequencing laboratories and GISAID EpiCoV group (Niko Beerenwinkel, The, Posada-Céspedes, Susana, Philipp, Kim, Jablonski, Falé Ferreira, Pedro, Topolsky, Ivan, Avšičžupanc, Tatjana, Korva, Miša, Poljak, Mario, Zakotnik, Samo, Tomaž, Zorec, Mark, Bragstad, Karoline, Hungnes, Olav, Stene-Johansen, Kathrine, Reusken, Chantal, Meijer, Adam, Vennema, Harry, Ruiz-Roldán, Lidia, Alma Bracho, María, García-González, Neri, Chiner-Oms, Álvaro, Cancino-Muñoz, Irving, Comas, Iñaki, A Goig, Galo, Torres-Puente, Manuela, G López, Mariana, Martínez-Priego, Llúcia, D’Auria, Giuseppe, LoretoFerrús-Abad, de Marco, Griselda, Galan-Vendrell, Inmaculada, Carbó-Ramirez, Sandra, Ruíz-Hueso, Paula, Coscollá, Mireia, Polackova, Katerina, Kramna, Lenka, Cinek, Ondrej, Richter, Jan, Krashias, George, Tryfonos, Christina, Bashiardes, Stavro, Koptides, Dana, Christodoulou, Christina, Bartolini, Barbara, Em Gruber, Cesare, Di Caro, Antonino, Castilletti, Concetta, Stefani, Fabrizio, Giordana Rimoldi, Sara, Romeri, Francesca, Salerno, Franco, Polesello, Stefano, Nagy, Alexander, Jirincova, Helena, Vecerova, Jaromira, Novakova, Ludmila, Cordey, Samuel, Murtskhvaladze, Marine, Kotaria, Nato, Schär, Tobia, Beisel, Christian, Vugrek, Oliver, Rokić, Filip, Trgovecgreif, Lovro, Jurak, Igor, Rukavina, Tomislav, Sučić, Neven, Schønning, Kristian, M Karst, Søren, H Kirkegaard, Rasmu, Y Michaelsen, Thoma, Aa Sørensen, Emil, Knutson, Simon, Brandt, Jakob, Le-Quy, Vang, Sørensen, Trine, Petersen, Celine, Schou Pedersen, Martin, Løkkegaard Larsen, Sanne, Nielsine Skov, Marianne, Rasmussen, Morten, Fonager, Jannik, Fomsgaard, Ander, Amirovich Maksyutov, Rinat, Vasil’Evna Gavrilova, Elena, Victorovich Pyankov, Oleg, Alexandrovich Bodnev, Sergey, Vladimirovna Tregubchak, Tatyana, Nikolayevich Shvalov, Alexander, Victorovich Antonets, Deni, Cristina Resende, Paola, Goya, Stephanie, Perrin, Amandine, Tc Lee, Raphael, Yadahalli, Shilpa, X Han, Alvin, A Russell, Colin, Schmutz, Stefan, Zaheri, Maryam, Kufner, Verena, Huber, Michael, Trkola, Alexandra, Antwerpen, Marku, C Walter, Mathia, van der Werf, Sylvie, Gambaro, Fabiana, Behillil, Sylvie, Enouf, Vincent, Donati, Flora, Ustinova, Monta, Rovite, Vita, Klovins, Jani, Savicka, Oksana, K Wienecke-Baldacchino, Anke, Ragimbeau, Catherine, Fournier, Guillaume, Mossong, Joël, W Aberle, Stephan, Haukland, Mattia, Enkirch, Theresa, Advani, Abdolreza, Lind Karlberg, Maria, Karlsson Lindsjö, Oskar, Broddesson, Sandra, Sláviková, Monika, Ličková, Martina, Klempa, Bori, Staroňová, Edita, Tichá, Elena, Szemes, Tomáš, Rusňáková, Diana, Stadler, Tanja, Quer, Josep, Anton, Andre, Andres, Cristina, Piñana, Maria, Garcia-Cehic, Damir, Pumarola, Toma, Izopet, Jacque, Gioula, Georgia, Exindari, Maria, Papa, Anna, Chatzidimitriou, Dimitrio, Metallidis, Symeon, Pappa, Stella, Macek Jr, Milan, Geryk, Jan, Brož, Petr, Briksí, Aleš, Hubáček, Petr, Dřevínek, Pavel, Zajac, Miroslav, Kvapil, Petr, Holub, Michal, Kvapilová, Kateřina, Novotný, Adam, Kašný, Martin, Klempt, Petr, Vapalahti, Olli, Smura, Teemu, Sironen, Tarja, Selhorst, Philippe, Anthony, Colin, Ariën, Kevin, Simon-Loriere, Etienne, Rabalski, Lukasz, Bienkowska-Szewczyk, Krystyna, Borges, Vítor, Isidro, Joana, Paulo Gomes, João, Guiomar, Raquel, Pechirra, Pedro, Costa, Inê, Duarte, Sílvia, Vieira, Luí, Pyrc, Krzysztof, S Zuckerman, Neta, Turdikulova, Shahlo, Abdullaev, Alisher, Dalimova, Dilbar, Abdurakhimov, Abror, Tagliabracci, Adriano, Alessandrini, Federica, Melchionda, Filomena, Onofri, Valerio, Turchi, Chiara, Bagnarelli, Patrizia, Menzo, Stefano, Caucci, Sara, Di Sante, Laura, Popa, Alexandra, Genger, Jakob-Wendelin, Agerer, Benedikt, Lercher, Alexander, Endler, Luka, Smyth, Mark, Penz, Thoma, Schuster, Michael, Senekowitsch, Martin, Laine, Jan, Bock, Christoph, Bergthaler, Andrea, Shevtsov, Alexandr, Kalendar, Ruslan, Ramanculov, Yerlan, Graf, Alexander, Muenchhoff, Maximilian, T Keppler, Oliver, Krebs, Stefan, Blum, Helmut, Marcello, Alessandro, Licastro, Danilo, D’Agaro, Pierlanfranco, Laubscher, Florian, Vidanovic, Dejan, Tesovic, Bojana, Volkening, Jeremy, Clementi, Nicola, Mancini, Nicasio, Rupnik, Maja, Mahnic, Aleksander, Walker, Andrea, Houwaart, Torsten, Wienemann, Tobia, Kohns Vasconcelos, Malte, Strelow, Daniel, Ole Jensen, Björn-Erik, Senff, Tina, Hülse, Lisanna, Adams, Ortwin, Andree, Marcel, Hauka, Sandra, Feldt, Torsten, Keitel, Verena, Kindgen-Milles, Detlef, Timm, Jörg, Pfeffer, Klau, T Dilthey, Alexander, Moore, Catherine, Ozdarendeli, Aykut, Terkis Islam Pavel, Shaikh, Yetiskin, Hazel, Aydin, Gunsu, Holyavkin, Can, Ali Uygut, Muhammet, Cevik, Ceren, Shchetinin, Alexey, Gushchin, Vladimir, Dinler-Doganay, Gizem, Doganay, Levent, Kizilboga-Akgun, Tugba, Karacan, Ilker, Pancer, Katarzyna, Maes, Piet, Martí-Carreras, Joan, Wawina-Bokalanga, Tony, Thürmer, Andrea, Wedde, Marianne, Dürrwald, Ralf, Von Kleist, Max, Drechsel, Oliver, Wolff, Thorsten, Fuchs, Stephan, Kmiecinski, Rene, Michel, Janine, Nitsche, Andrea, Casas, Inmaculada, Iglesias Caballero, María, Zaballos, Ángel, Jiménez, Pilar, Jiménez, Mercede, Monzón Fernández, Sara, Varona Fernández, Sarai, Cuesta De La Plaza, Isabel, Fadeev, Artem, Ivanova, Anna, Sergeeva, Mariia, Stefanelli, Paola, Estee Torok, M, Hall, Grant, da Silva Filipe, Ana, Turtle, Lance, Afifi, Safiah, Mccluggage, Kathryn, Beer, Robert, Ledesma, Juan, Maksimovic, Joshua, Spellman, Karla, L Hamilton, William, Marchbank, Angela, Alexander Southgate, Joel, Underwood, Anthony, Taylor, Ben, Yeats, Corin, Abudahab, Khalil, R Gemmell, Matthew, Eccles, Richard, Lucaci, Anita, Abigail Nelson, Charlotte, Rainbow, Lucille, Whitehead, Mark, Gregory, Richard, Haldenby, Sam, Paterson, Steve, A Hughes, Margaret, D Curran, Martin, Baker, David, Tucker, Rachel, R Green, Luke, Feltwell, Theresa, D Halstead, Fenella, Wyles, Matthew, S Jahun, Aminu, Y Ahmad, Shazaad S, Georgana, Iliana, Goodfellow, Ian, Yakovleva, Anna, W Meredith, Luke, Gavriil, Artemi, Raza Awan, Ali, Fisher, Chloe, Jonathan, European Centre for Disease Prevention and Control [Stockholm, Sweden] (ECDC), Cardiff University, Public Health Wales [Cardiff, Royaume uni], University of Basel (Unibas), Research Institute of Influenza, St. Petersburg, Russia, Agency for science, technology and research [Singapore] (A*STAR), National University of Singapore (NUS), University of Edinburgh, WHO Regional Office for Europe [Copenhagen], We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID’s EpiCoV Database used in the phylogenetic analysis. We gratefully acknowledge all the staff working with sample collection, sample preparation, sequencing, data analysis and data sharing in all laboratories in the WHO European Region for making this work possible, The WHO European Region sequencing laboratories and GISAID EpiCoV group*: Niko Beerenwinkel, Susana Posada-Céspedes, Kim Philipp Jablonski, Pedro Falé Ferreira, Ivan Topolsky, Tatjana Avšič-Županc, Miša Korva, Mario Poljak, Samo Zakotnik, Tomaž Mark Zorec, Karoline Bragstad, Olav Hungnes, Kathrine Stene-Johansen, Chantal Reusken, Adam Meijer, Harry Vennema, Lidia Ruiz-Roldán, María Alma Bracho, Neris García-González, Álvaro Chiner-Oms, Irving Cancino-Muñoz, Iñaki Comas, Galo A Goig, Manuela Torres-Puente, Mariana G López, Llúcia Martínez-Priego, Giuseppe D'Auria, Paula Ruíz-Hueso, Loreto Ferrús-Abad, Griselda de Marco, Inmaculada Galan-Vendrell, Sandra Carbó-Ramirez, Paula Ruiz-Rodriguez, Mireia Coscollá, Katerina Polackova, Lenka Kramna, Ondrej Cinek, Jan Richter, George Krashias, Christina Tryfonos, Stavros Bashiardes, Dana Koptides, Christina Christodoulou, Barbara Bartolini, Cesare Em Gruber, Antonino Di Caro, Concetta Castilletti, Fabrizio Stefani, Sara Giordana Rimoldi, Francesca Romeri, Franco Salerno, Stefano Polesello, Alexander Nagy, Helena Jirincova, Jaromira Vecerova, Ludmila Novakova, Samuel Cordey, Marine Murtskhvaladze, Nato Kotaria, Tobias Schär, Christian Beisel, Oliver Vugrek, Filip Rokić, Lovro Trgovec-Greif, Igor Jurak, Tomislav Rukavina, Neven Sučić, Kristian Schønning, Søren M Karst, Rasmus H Kirkegaard, Thomas Y Michaelsen, Emil Aa Sørensen, Simon Knutson, Jakob Brandt, Vang Le-Quy, Trine Sørensen, Celine Petersen, Martin Schou Pedersen, Sanne Løkkegaard Larsen, Marianne Nielsine Skov, Morten Rasmussen, Jannik Fonager, Anders Fomsgaard, Rinat Amirovich Maksyutov, Elena Vasil'Evna Gavrilova, Oleg Victorovich Pyankov, Sergey Alexandrovich Bodnev, Tatyana Vladimirovna Tregubchak, Alexander Nikolayevich Shvalov, Denis Victorovich Antonets, Paola Cristina Resende, Stephanie Goya, Amandine Perrin, Raphael Tc Lee, Shilpa Yadahalli, Alvin X Han, Colin A Russell, Stefan Schmutz, Maryam Zaheri, Verena Kufner, Michael Huber, Alexandra Trkola, Markus Antwerpen, Mathias C Walter, Sylvie van der Werf, Fabiana Gambaro, Sylvie Behillil, Vincent Enouf, Flora Donati, Monta Ustinova, Vita Rovite, Janis Klovins, Oksana Savicka, Anke K Wienecke-Baldacchino, Catherine Ragimbeau, Guillaume Fournier, Joël Mossong, Stephan W Aberle, Mattias Haukland, Theresa Enkirch, Abdolreza Advani, Maria Lind Karlberg, Oskar Karlsson Lindsjö, Sandra Broddesson, Monika Sláviková, Martina Ličková, Boris Klempa, Edita Staroňová, Elena Tichá, Tomáš Szemes, Diana Rusňáková, Tanja Stadler, Josep Quer, Andres Anton, Cristina Andres, Maria Piñana, Damir Garcia-Cehic, Tomas Pumarola, Jacques Izopet, Georgia Gioula, Maria Exindari, Anna Papa, Dimitrios Chatzidimitriou, Symeon Metallidis, Stella Pappa, Milan Macek Jr, Jan Geryk, Petr Brož, Aleš Briksí, Petr Hubáček, Pavel Dřevínek, Miroslav Zajac, Petr Kvapil, Michal Holub, Kateřina Kvapilová, Adam Novotný, Martin Kašný, Petr Klempt, Olli Vapalahti, Teemu Smura, Tarja Sironen, Philippe Selhorst, Colin Anthony, Kevin Ariën, Etienne Simon-Loriere, Lukasz Rabalski, Krystyna Bienkowska-Szewczyk, Vítor Borges, Joana Isidro, João Paulo Gomes, Raquel Guiomar, Pedro Pechirra, Inês Costa, Sílvia Duarte, Luís Vieira, Krzysztof Pyrc, Neta S Zuckerman, Shahlo Turdikulova, Alisher Abdullaev, Dilbar Dalimova, Abror Abdurakhimov, Adriano Tagliabracci, Federica Alessandrini, Filomena Melchionda, Valerio Onofri, Chiara Turchi, Patrizia Bagnarelli, Stefano Menzo, Sara Caucci, Laura Di Sante, Alexandra Popa, Jakob-Wendelin Genger, Benedikt Agerer, Alexander Lercher, Lukas Endler, Mark Smyth, Thomas Penz, Michael Schuster, Martin Senekowitsch, Jan Laine, Christoph Bock, Andreas Bergthaler, Alexandr Shevtsov, Ruslan Kalendar, Yerlan Ramanculov, Alexander Graf, Maximilian Muenchhoff, Oliver T Keppler, Stefan Krebs, Helmut Blum, Alessandro Marcello, Danilo Licastro, Pierlanfranco D'Agaro, Florian Laubscher, Dejan Vidanovic, Bojana Tesovic, Jeremy Volkening, Nicola Clementi, Nicasio Mancini, Maja Rupnik, Aleksander Mahnic, Andreas Walker, Torsten Houwaart, Tobias Wienemann, Malte Kohns Vasconcelos, Daniel Strelow, Björn-Erik Ole Jensen, Tina Senff, Lisanna Hülse, Ortwin Adams, Marcel Andree, Sandra Hauka, Torsten Feldt, Verena Keitel, Detlef Kindgen-Milles, Jörg Timm, Klaus Pfeffer, Alexander T Dilthey, Catherine Moore, Aykut Ozdarendeli, Shaikh Terkis Islam Pavel, Hazel Yetiskin, Gunsu Aydin, Can Holyavkin, Muhammet Ali Uygut, Ceren Cevik, Alexey Shchetinin, Vladimir Gushchin, Gizem Dinler-Doganay, Levent Doganay, Tugba Kizilboga-Akgun, Ilker Karacan, Katarzyna Pancer, Piet Maes, Joan Martí-Carreras, Tony Wawina-Bokalanga, Bert Vanmechelen, Andrea Thürmer, Marianne Wedde, Ralf Dürrwald, Max Von Kleist, Oliver Drechsel, Thorsten Wolff, Stephan Fuchs, Rene Kmiecinski, Janine Michel, Andreas Nitsche, Inmaculada Casas, María Iglesias Caballero, Ángel Zaballos, Pilar Jiménez, Mercedes Jiménez, Sara Monzón Fernández, Sarai Varona Fernández, Isabel Cuesta De La Plaza, Artem Fadeev, Anna Ivanova, Mariia Sergeeva, Paola Stefanelli, M Estee Torok, Grant Hall, Ana da Silva Filipe, Lance Turtle, Safiah Afifi, Kathryn Mccluggage, Robert Beer, Juan Ledesma, Joshua Maksimovic, Karla Spellman, William L Hamilton, Angela Marchbank, Joel Alexander Southgate, Anthony Underwood, Ben Taylor, Corin Yeats, Khalil Abudahab, Matthew R Gemmell, Richard Eccles, Anita Lucaci, Charlotte Abigail Nelson, Lucille Rainbow, Mark Whitehead, Richard Gregory, Sam Haldenby, Steve Paterson, Margaret A Hughes, Martin D Curran, David Baker, Rachel Tucker, Luke R Green, Theresa Feltwell, Fenella D Halstead, Matthew Wyles, Aminu S Jahun, Shazaad S Y Ahmad, Iliana Georgana, Ian Goodfellow, Anna Yakovleva, Luke W Meredith, Artemis Gavriil, Ali Raza Awan, Chloe Fisher, Jonathan Edgeworth, Jessica Lynch, Nathan Moore, Rebecca Williams, Stephen P Kidd, Nicholas Cortes, Kirstyn Brunker, John T Mccrone, Joshua Quick, Nichola Duckworth, Sarah Walsh, Tim Sloan, Catherine Ludden, Ryan P George, Gary Eltringham, Julianne R Brown, Elihu Aranday-Cortes, James G Shepherd, Joseph Hughes, Kathy K Li, Thomas C Williams, Natasha Johnson, Natasha Jesudason, Daniel Mair, Emma Thomson, Rajiv Shah, Yasmin A Parr, Stephen Carmichael, David L Robertson, Kyriaki Nomikou, Alice Broos, Marc Niebel, Katherine Smollett, Lily Tong, Shahjahan Miah, Anita Wittner, Nicole Phillips, Brendan Payne, Rebecca Dewar, Alison Holmes, Frances Bolt, James R Price, Siddharth Mookerjee, Dheeraj K Sethi, Will Potter, Rachael Stanley, Reenesh Prakash, Samir Dervisevic, Jonathan Clive Graham, Andrew Nelson, Darren Smith, Gregory R Young, Wen Chyin Yew, John A Todd, Amy Trebes, Monique Andersson, Matthew Bull, Joanne Watkins, Alec Birchley, Bree Gatica-Wilcox, Lauren Gilbert, Sara Kumžiene-Summerhayes, Sara Rey, Anoop Chauhan, Ethan Butcher, Kelly Bicknell, Scott Elliott, Sharon Glaysher, Angie Lackenby, David Bibby, Steven Platt, Hodan Mohamed, Nicholas William Machin, Jean Lutamyo Mbisa, Jonathan Evans, Malorie Perry, Nicole Pacchiarini, Sally Corden, Alexander Geraint Adams, Amy Gaskin, Jason Coombs, Lee John Graham, Simon Cottrell, Mari Morgan, Laura Gifford, Anastasia Kolyva, Steven John Rudder, Alexander J Trotter, Alison E Mather, Alp Aydin, Andrew J Page, Gemma L Kay, Leonardo de Oliveira Martins, Muhammad Yasir, Nabil-Fareed Alikhan, Nicholas M Thomson, Rachel Gilroy, Robert A Kingsley, Justin O'Grady, Ana Victoria Gutierrez, Maria Diaz, Thanh Le Viet, Ana P Tedim, Evelien M Adriaenssens, C Patrick Mcclure, Christopher Moore, Fei Sang, Gemma Clark, Hannah C Howson-Wells, Johnny Debebe, Jonathan Ball, Joseph Chappell, Manjinder Khakh, Matthew Carlile, Matthew Loose, Michelle M Lister, Nadine Holmes, Theocharis Tsoleridis, Vicki M Fleming, Victoria Wright, Wendy Smith, Michael D Gallagher, Matthew Parker, David G Partridge, Cariad Evans, Paul Baker, Sarah Essex, Steven Liggett, Alexander J Keeley, Matthew Bashton, Stefan Rooke, Samir Dervisevic, Emma Jane Meader, Carlos Enrique Balcazar Lopez, Adrienn Angyal, Mark Kristiansen, Helena J Tutill, Jacqueline Findlay, Lamia Mestek-Boukhibar, Leysa Forrest, Patricia Dyal, Rachel J Williams, Yasmin Panchbhaya, Charlotte A Williams, Sunando Roy, Sarojini Pandey, Jo Stockton, Nicholas J Loman, Radoslaw Poplawski, Samuel Nicholls, W P M Rowe, Fahad Khokhar, Malte Lars Pinckert, Myra Hosmillo, Yasmin Chaudhry, Laura G Caller, Rose K Davidson, Luke Griffith, Andrew Rambaut, Ben Jackson, Rachel Colquhoun, Verity Hill, Jenna Nichols, Patawee Asamaphan, Alistair Darby, Kathryn A Jackson, Miren Iturriza-Gomara, Ecaterina Edith Vamos, Angie Green, David Aanensen, David Bonsall, David Buck, George Macintyre-Cockett, Mariateresa de Cesare, Oliver Pybus, Tanya Golubchik, Garry Scarlett, Katie F Loveson, Samuel C Robson, Angela Beckett, Benjamin Lindsey, Danielle C Groves, Paul J Parsons, Martin P Mchugh, James Daniel Barnes, Carmen F Manso, Dimitris Grammatopoulos, Katja Elisabeth Menger, Ewan Harrison, Rory Gunson, Sharon J Peacock, Gabriel Gonzalez, Michael Carr, Lazar Mihaela, Odette Popovici, Mia Brytting, Catherine Bresner, William Fuller, Trudy Workman, Andreas F Mentis, Athanasios Kossyvakis, Timokratis Karamitros, Vasiliki Pogka, Antonios Kalliaropoulos, Elina Horefti, Aspasia Kontou, Beatriz Martinez-Gonzalez, Voula Labropoulou, Androniki Voulgari-Kokota, Maria Evangelidou, Panagiota Bizta, Maria Belimezi, Laurens Lambrechts, Mehmet Z Doymaz, Merve Kalkan Yazici, Nesibe S Cetin, Elif Karaaslan, Hannimari Kallio-Kokko, Jenni Virtanen, Maija Suvanto, Phuoc Truong Nguyen, Pekka Ellonen, Sari Hannula, Harri Kangas, Vattipally B Sreenu, Katalin Burián, Gabriella Terhes, Katalin Gombos, Attila Gyenesei, Péter Urbán, Róbert Herczeg, Ferenc Jakab, Gábor Kemenesi, Gábor Endre Tóth, Balázs Somogyi, Brigitta Zana, Safia Zeghbib, Anett Kuczmog, Fanni Földes, Zsófia Lanszki, Mónika Madai, Henrietta Papp, Ágnes Nagy, Csaba István Pereszlényi, Gergely Csaba Babinszky, Gábor Dudás, Eszter Csoma, Ahmad N Abou Tayoun, Alawi A Alsheikh-Ali, Tom Loney, Norbert Nowotny, Osama Abdul-Wahab, Fernando Gonzalez-Candelas, Martin H Andersen, Sarah Taylor, Comas, Iñaki [0000-0001-5504-9408], Alm, E., Broberg, E. K., Connor, T., Hodcroft, E. B., Komissarov, A. B., Maurer-Stroh, S., Melidou, A., Neher, R. A., O'Toole, A., Pereyaslov, D., Beerenwinkel, N., Posada-Cespedes, S., Jablonski, K. P., Ferreira, P. F., Topolsky, I., Avsic-Zupanc, T., Korva, M., Poljak, M., Zakotnik, S., Zorec, T. M., Bragstad, K., Hungnes, O., Stene-Johansen, K., Reusken, C., Meijer, A., Vennema, H., Ruiz-Roldan, L., Bracho, M. A., Garcia-Gonzalez, N., Chiner-Oms, A., Cancino-Munoz, I., Comas, I., Goig, G. A., Torres-Puente, M., Lopez, M. G., Martinez-Priego, L., D'Auria, G., Ruiz-Hueso, P., Ferrus-Abad, L., de Marco, G., Galan-Vendrell, I., Carbo-Ramirez, S., Ruiz-Rodriguez, P., Coscolla, M., Polackova, K., Kramna, L., Cinek, O., Richter, J., Krashias, G., Tryfonos, C., Bashiardes, S., Koptides, D., Christodoulou, C., Bartolini, B., Gruber, C. E., Di Caro, A., Castilletti, C., Stefani, F., Rimoldi, S. G., Romeri, F., Salerno, F., Polesello, S., Nagy, A., Jirincova, H., Vecerova, J., Novakova, L., Cordey, S., Murtskhvaladze, M., Kotaria, N., Schar, T., Beisel, C., Vugrek, O., Rokic, F., Trgovec-Greif, L., Jurak, I., Rukavina, T., Sucic, N., Schonning, K., Karst, S. M., Kirkegaard, R. H., Michaelsen, T. Y., Sorensen, E. A., Knutson, S., Brandt, J., Le-Quy, V., Sorensen, T., Petersen, C., Pedersen, M. S., Larsen, S. L., Skov, M. N., Rasmussen, M., Fonager, J., Fomsgaard, A., Maksyutov, R. A., Gavrilova, E. V., Pyankov, O. V., Bodnev, S. A., Tregubchak, T. V., Shvalov, A. N., Antonets, D. V., Resende, P. C., Goya, S., Perrin, A., Lee, R. T., Yadahalli, S., Han, A. X., Russell, C. A., Schmutz, S., Zaheri, M., Kufner, V., Huber, M., Trkola, A., Antwerpen, M., Walter, M. C., van der Werf, S., Gambaro, F., Behillil, S., Enouf, V., Donati, F., Ustinova, M., Rovite, V., Klovins, J., Savicka, O., Wienecke-Baldacchino, A. K., Ragimbeau, C., Fournier, G., Mossong, J., Aberle, S. W., Haukland, M., Enkirch, T., Advani, A., Karlberg, M. L., Lindsjo, O. K., Broddesson, S., Slavikova, M., Lickova, M., Klempa, B., Staronova, E., Ticha, E., Szemes, T., Rusnakova, D., Stadler, T., Quer, J., Anton, A., Andres, C., Pinana, M., Garcia-Cehic, D., Pumarola, T., Izopet, J., Gioula, G., Exindari, M., Papa, A., Chatzidimitriou, D., Metallidis, S., Pappa, S., Macek, M., Geryk, J., Broz, P., Briksi, A., Hubacek, P., Drevinek, P., Zajac, M., Kvapil, P., Holub, M., Kvapilova, K., Novotny, A., Kasny, M., Klempt, P., Vapalahti, O., Smura, T., Sironen, T., Selhorst, P., Anthony, C., Arien, K., Simon-Loriere, E., Rabalski, L., Bienkowska-Szewczyk, K., Borges, V., Isidro, J., Gomes, J. P., Guiomar, R., Pechirra, P., Costa, I., Duarte, S., Vieira, L., Pyrc, K., Zuckerman, N. S., Turdikulova, S., Abdullaev, A., Dalimova, D., Abdurakhimov, A., Tagliabracci, A., Alessandrini, F., Melchionda, F., Onofri, V., Turchi, C., Bagnarelli, P., Menzo, S., Caucci, S., Di Sante, L., Popa, A., Genger, J. -W., Agerer, B., Lercher, A., Endler, L., Smyth, M., Penz, T., Schuster, M., Senekowitsch, M., Laine, J., Bock, C., Bergthaler, A., Shevtsov, A., Kalendar, R., Ramanculov, Y., Graf, A., Muenchhoff, M., Keppler, O. T., Krebs, S., Blum, H., Marcello, A., Licastro, D., D'Agaro, P., Laubscher, F., Vidanovic, D., Tesovic, B., Volkening, J., Clementi, N., Mancini, N., Rupnik, M., Mahnic, A., Walker, A., Houwaart, T., Wienemann, T., Vasconcelos, M. K., Strelow, D., Jensen, B. -E. O., Senff, T., Hulse, L., Adams, O., Andree, M., Hauka, S., Feldt, T., Keitel, V., Kindgen-Milles, D., Timm, J., Pfeffer, K., Dilthey, A. T., Moore, C., Ozdarendeli, A., Pavel, S. T. I., Yetiskin, H., Aydin, G., Holyavkin, C., Uygut, M. A., Cevik, C., Shchetinin, A., Gushchin, V., Dinler-Doganay, G., Doganay, L., Kizilboga-Akgun, T., Karacan, I., Pancer, K., Maes, P., Marti-Carreras, J., Wawina-Bokalanga, T., Vanmechelen, B., Thurmer, A., Wedde, M., Durrwald, R., von Kleist, M., Drechsel, O., Wolff, T., Fuchs, S., Kmiecinski, R., Michel, J., Nitsche, A., Casas, I., Caballero, M. I., Zaballos, A., Jimenez, P., Jimenez, M., Fernandez, S. M., Fernandez, S. V., de la Plaza, I. C., Fadeev, A., Ivanova, A., Sergeeva, M., Stefanelli, P., Estee Torok, M., Hall, G., da Silva Filipe, A., Turtle, L., Afifi, S., Mccluggage, K., Beer, R., Ledesma, J., Maksimovic, J., Spellman, K., Hamilton, W. L., Marchbank, A., Southgate, J. A., Underwood, A., Taylor, B., Yeats, C., Abudahab, K., Gemmell, M. R., Eccles, R., Lucaci, A., Nelson, C. A., Rainbow, L., Whitehead, M., Gregory, R., Haldenby, S., Paterson, S., Hughes, M. A., Curran, M. D., Baker, D., Tucker, R., Green, L. R., Feltwell, T., Halstead, F. D., Wyles, M., Jahun, A. S., Ahmad, S. S. Y., Georgana, I., Goodfellow, I., Yakovleva, A., Meredith, L. W., Gavriil, A., Awan, A. R., Fisher, C., Edgeworth, J., Lynch, J., Moore, N., Williams, R., Kidd, S. P., Cortes, N., Brunker, K., Mccrone, J. T., Quick, J., Duckworth, N., Walsh, S., Sloan, T., Ludden, C., George, R. P., Eltringham, G., Brown, J. R., Aranday-Cortes, E., Shepherd, J. G., Hughes, J., Li, K. K., Williams, T. C., Johnson, N., Jesudason, N., Mair, D., Thomson, E., Shah, R., Parr, Y. A., Carmichael, S., Robertson, D. L., Nomikou, K., Broos, A., Niebel, M., Smollett, K., Tong, L., Miah, S., Wittner, A., Phillips, N., Payne, B., Dewar, R., Holmes, A., Bolt, F., Price, J. R., Mookerjee, S., Sethi, D. K., Potter, W., Stanley, R., Prakash, R., Dervisevic, S., Graham, J. C., Nelson, A., Smith, D., Young, G. R., Yew, W. C., Todd, J. A., Trebes, A., Andersson, M., Bull, M., Watkins, J., Birchley, A., Gatica-Wilcox, B., Gilbert, L., Kumziene-Summerhayes, S., Rey, S., Chauhan, A., Butcher, E., Bicknell, K., Elliott, S., Glaysher, S., Lackenby, A., Bibby, D., Platt, S., Mohamed, H., Machin, N. W., Mbisa, J. L., Evans, J., Perry, M., Pacchiarini, N., Corden, S., Adams, A. G., Gaskin, A., Coombs, J., Graham, L. J., Cottrell, S., Morgan, M., Gifford, L., Kolyva, A., Rudder, S. J., Trotter, A. J., Mather, A. E., Aydin, A., Page, A. J., Kay, G. L., de Oliveira Martins, L., Yasir, M., Alikhan, N. -F., Thomson, N. M., Gilroy, R., Kingsley, R. A., O'Grady, J., Gutierrez, A. V., Diaz, M., Viet, T. L., Tedim, A. P., Adriaenssens, E. M., Patrick Mcclure, C., Sang, F., Clark, G., Howson-Wells, H. C., Debebe, J., Ball, J., Chappell, J., Khakh, M., Carlile, M., Loose, M., Lister, M. M., Holmes, N., Tsoleridis, T., Fleming, V. M., Wright, V., Smith, W., Gallagher, M. D., Parker, M., Partridge, D. G., Evans, C., Baker, P., Essex, S., Liggett, S., Keeley, A. J., Bashton, M., Rooke, S., Dervisavic, S., Meader, E. J., Lopez, C. E. B., Angyal, A., Kristiansen, M., Tutill, H. J., Findlay, J., Mestek-Boukhibar, L., Forrest, L., Dyal, P., Williams, R. J., Panchbhaya, Y., Williams, C. A., Roy, S., Pandey, S., Stockton, J., Loman, N. J., Poplawski, R., Nicholls, S., Rowe, W. P. M., Khokhar, F., Pinckert, M. L., Hosmillo, M., Chaudhry, Y., Caller, L. G., Davidson, R. K., Griffith, L., Rambaut, A., Jackson, B., Colquhoun, R., Hill, V., Nichols, J., Asamaphan, P., Darby, A., Jackson, K. A., Iturriza-Gomara, M., Vamos, E. E., Green, A., Aanensen, D., Bonsall, D., Buck, D., Macintyre-Cockett, G., de Cesare, M., Pybus, O., Golubchik, T., Scarlett, G., Loveson, K. F., Robson, S. C., Beckett, A., Lindsey, B., Groves, D. C., Parsons, P. J., Mchugh, M. P., Barnes, J. D., Manso, C. F., Grammatopoulos, D., Menger, K. E., Harrison, E., Gunson, R., Peacock, S. J., Gonzalez, G., Carr, M., Mihaela, L., Popovici, O., Brytting, M., Bresner, C., Fuller, W., Workman, T., Mentis, A. F., Kossyvakis, A., Karamitros, T., Pogka, V., Kalliaropoulos, A., Horefti, E., Kontou, A., Martinez-Gonzalez, B., Labropoulou, V., Voulgari-Kokota, A., Evangelidou, M., Bizta, P., Belimezi, M., Lambrechts, L., Doymaz, M. Z., Yazici, M. K., Cetin, N. S., Karaaslan, E., Kallio-Kokko, H., Virtanen, J., Suvanto, M., Nguyen, P. T., Ellonen, P., Hannula, S., Kangas, H., Sreenu, V. B., Burian, K., Terhes, G., Gombos, K., Gyenesei, A., Urban, P., Herczeg, R., Jakab, F., Kemenesi, G., Toth, G. E., Somogyi, B., Zana, B., Zeghbib, S., Kuczmog, A., Foldes, F., Lanszki, Z., Madai, M., Papp, H., Pereszlenyi, C. I., Babinszky, G. C., Dudas, G., Csoma, E., Abou Tayoun, A. N., Alsheikh-Ali, A. A., Loney, T., Nowotny, N., Abdul-Wahab, O., Gonzalez-Candelas, F., Andersen, M. H., Taylor, S., European Centre for Disease Prevention and Control (ECDC), Public Health Wales Microbiology Cardiff, Faculty of Agriculture and Forestry, Department of Agricultural Sciences, and Institute of Biotechnology
- Subjects
Infecções Respiratórias ,0301 basic medicine ,MESH: Coronavirus Infections ,Epidemiology ,[SDV]Life Sciences [q-bio] ,Distribution (economics) ,Wastewater ,MESH: Base Sequence ,Severe Acute Respiratory Syndrome ,MESH: World Health Organization ,Pandemic ,MESH: Coronavirus ,MESH: COVID-19 ,Sequencing ,Viral ,Clade ,Nomenclature ,Genome ,biology ,COVID-19 ,Europe ,NGS ,SARS-CoV-2 ,WGS ,nomenclature ,sequencing ,Base Sequence ,Betacoronavirus ,Coronavirus ,Coronavirus Infections ,Genome, Viral ,Humans ,Phylogeography ,Pneumonia, Viral ,RNA, Viral ,RNA-Dependent RNA Polymerase ,Spatio-Temporal Analysis ,World Health Organization ,Pandemics ,C500 ,European region ,3. Good health ,Geography ,MESH: Phylogeography ,MESH: RNA-Dependent RNA Polymerase ,MESH: RNA, Viral ,MESH: Betacoronavirus ,Spatio-Temporal Analysi ,MESH: Genome, Viral ,Cartography ,Human ,Bioquímica ,MESH: Pandemics ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Coronaviru ,030106 microbiology ,03 medical and health sciences ,MESH: Spatio-Temporal Analysis ,MESH: Severe Acute Respiratory Syndrome ,Virology ,MESH: SARS-CoV-2 ,Whole genome sequencing ,MESH: Humans ,Whole Genome Sequencing ,Betacoronaviru ,Coronavirus Infection ,business.industry ,Public Health, Environmental and Occupational Health ,Pneumonia ,biology.organism_classification ,B900 ,030104 developmental biology ,MESH: Pneumonia, Viral ,RNA ,SARS_CoV-2 ,3111 Biomedicine ,MESH: Europe ,Human medicine ,business - Abstract
8 páginas, 3 figuras, We show the distribution of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genetic clades over time and between countries and outline potential genomic surveillance objectives. We applied three genomic nomenclature systems to all sequence data from the World Health Organization European Region available until 10 July 2020. We highlight the importance of real-time sequencing and data dissemination in a pandemic situation, compare the nomenclatures and lay a foundation for future European genomic surveillance of SARS-CoV-2., We gratefully acknowledge the authors, originating and submitting laboratories of the sequences from GISAID’s EpiCoV Database used in the phylogenetic analysis. We gratefully acknowledge all the staff working with sample collection, sample preparation, sequencing, data analysis and data sharing in all laboratories in the WHO European Region for making this work possible.
- Full Text
- View/download PDF
9. Helicobacter pylori in oral aphthous ulcers.
- Author
-
Pavelić, J, Gall-Troselj, K, Jurak, I, and Mravak-Stipetić, M
- Subjects
HELICOBACTER pylori ,ORAL mucosa ,CANKER sores - Published
- 2000
- Full Text
- View/download PDF
10. Importance of changed tongue mucosa for Helicobacter pylori colonization
- Author
-
Koraljka Gall Troselj, Jurak, I., Mravak-Stipetic, M., and Pavelic, J.
- Subjects
H. pylori ,transmission ,oral cavity - Abstract
Helicobacter pylori is able to colonize gastric epithelia and cause chronic active gastritis, gastric and duodenal ulcers and presumably gastric malignancies (4). Attempts to identify the natural reservoir for this microorganism other than stomach have been unsuccessful for many years (15). Results published by Grubel et al. suggest that houseflies can harbor viable H. pylori on their bodies as well as in their intestinal tract, they are able to disseminate viable H. pylori in excreta, and may therefore present a potential reservoir and be a vector in transmission of bacteria (7). Based on an animal model, Yoshimatsu et al. concluded that H. pylori might be transmitted through a fecal-oral route from challenged to nonchallenged nude mice. After coercing challenged and nonchallenged animals fro two and four weeks, its presence was detected in 50% and 70% of mice, respectively. Most importantly, no transmission occurred in mice not exposed to feces of challenged mouse while sharing food and water in the same cage (26). Based on their resuts, the possibility of oral-oral transmission does not seem plausible.
11. Ukorak s vremenom: trendovi u kronobiologiji i značaj cirkadijurnih ritmova za zdravstvene profesije
- Author
-
Bašić, Edita, Kocijan, Ivna, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., Županić, M., and Čengić, T.
- Subjects
cirkadijurni ritam ,biološki sat ,kronobiologija ,kronodisrupcija ,zdravstvene profesije - Abstract
Cirkadijurni ritmovi su prirodni, unutarnji procesi koji se ponavljaju svaka 24 sata i reguliraju cikluse budnosti i spavanja i brojne fiziološke funkcije. Cirkadijurni ritam određuje i kontrolira procese i aktivnosti poput spavanja, probave, tjelesne temperature, regulacije i proizvodnje hormona, razine fizičke aktivnosti, kognitivnih sposobnosti, mentalnog stanja, imunosnog sustav, starenja i regeneracije stanica, te još mnogo toga. Iako su cirkadijurni ritmovi endogeni, oni se prilagođavaju okolišnim čimbenicima, tzv. zeitgeberima, kao što su svjetlost, temperatura, hrana, fizička aktivnost, itd. Cirkadijurni su ritmovi bitno svojstvo fiziologije organizma i stanica jer koordiniraju mnoge metaboličke, biosintetske i signalne putove u organizmu. Molekularni mehanizam cirkadijurnog ritma kontroliran je transkripcijom gena i metaboličkom procesima u stanici. Kronodisrupcija ili poremećaj unutarnjeg biološkog sata dovodi organizam u stanje disbalansa koje može rezultirati smetnjama u obavljanju svakodnevnih aktivnosti i pojavom bolesti. Napredak istraživanja na području kronobiologije otvara put razvoju krono-nutricionizma (prehrana u skladu s cirkadijurnim ritmovima), krono-farmakologije (pravovremeno konzumiranje farmakoloških pripravaka), krono-terapije (terapija usklađena s rasporedom cirkadijurnih ritmova) i ostalih primjena spoznaja o cirkadijurnim ritmovima koje imaju za cilj povećati učinkovitost i minimalizirati nuspojave terapije. Poznavanje kronobiologije, odnosno cirkadijurnih ritmova, može biti vrlo korisno, kako običnome čovjeku, tako i zdravstvenim djelatnicima, primjerice u organizaciji smjenskog rada, ali i u pristupu pacijentima kojima zdravstveni djelatnici mogu uvelike pomoći da poboljšaju tijek terapije, umanje nuspojave, poprave pacijentovo psiho- emocionalno stanje i ubrzaju izlječenje.
- Published
- 2021
12. Implementacija suvremenih tehnologija u edukaciji fizioterapeuta i radnih terapeuta na Zdravstvenom veleučilištu
- Author
-
Kiseljak, Dalibor, Rađenović, Ozren, Kocijan, Ivna, Jurak, Ivan, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., Županić, M., and Čengić, T.
- Subjects
primijenjena biomehanika ,edukacija ,biomehanički laboratorij - Abstract
U cilju što kvalitetnije edukacije budućih fizioterapeuta i radnih terapeuta, Zdravstveno veleučilište nabavilo je dostupne, suvremene tehnologije koje će tvoriti okosnicu novog Laboratorija za primijenjenu biomehaniku pri Katedri za kineziologiju: platformu za mjerenje sila reakcija podloge Vernier te sustav s programskom podrškom Vernier Graphical Analysis, kao i računalni sustav Kinovea. Uz već postojeći mjerni uređaj BIOPAC MP35 i pripadajući računalni program BSL Software v.4.1.3PRO, navedeno je u funkciji praćenja i snimanja podataka u realnom vremenu u svrhu mjerenja koje objedinjuje biomehaničke i fiziološke parametre. Proces mjerenja, u kojem studenti sudjeluju kroz vježbe, služi za njihovo upoznavanje s postojećim tehnologijama mjerenja pokreta, ali i kao potencijalni prostor za istraživački rad. Suvremene oblike nastave predstavlja i učenje u e- okruženju uz održavanje nastave na on-line platformi kao što je Moodle ili pomoću aplikacija koje omogućuju istovremeno uključivanje velikog broja studenata i praćenje nastave uživo. Prelaskom na on-line nastavu bilo je potrebno u kratkom vremenu prilagoditi nastavu koja se do tada održavala u praktikumu, a u kojoj su kombinirane računalne simulacije i sustav Biopac, praćenje i izračun kretanja težišta tijela i akvizicija pojedinih kutova u zglobovima pomoću Kinovea sustava i to na način da se postigne što je moguće sličnije ishode unatoč otežanim okolnostima. Napravljene su video-snimke mjerenja koje su postavljene u e-kolegije zajedno sa snimkama računalne analize podataka, iz čega su studenti mogli pratiti izvođenje vježbe, očitati izmjerene podatke i obraditi ih prema uputama. U tijeku je i postupak prebacivanja Vernier sustava na on-line oblik praćenja vježbi. Iako je on-line nastava bila nužna zamjena za praktičnu nastavu, na opisani je način ipak u velikoj mjeri studentima omogućeno stjecanje praktičnog znanja koje će moći primijeniti u nastavku studija i budućem radu.
- Published
- 2021
13. Usamljenost žena starije životne dobi u Desiniću
- Author
-
Kranjčec, Diana, Hercigonja-Szekeres, Mira, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., and Županić, M
- Subjects
usamljenost žena ,starija životna dob ,socijalna podrška ,čimbenici rizika usamljenosti - Abstract
Usamljenost je subjektivno stanje povezano s negativnim emocijama zbog socijalne izolacije, nedostatnih socijalnih kontakata ili gubitka bliske osobe. Negativno utječe na zdravlje i kvalitetu života. Suprotno očekivanjima, mnogi ljudi iako okruženi ljudima su usamljeni. Najraširenija je među starijim osobama, dakle u dobi 65+, osobito ženama čiji je životni vijek dulji.
- Published
- 2020
14. Kineziofobija kod skijaša s ozljedom koljena
- Author
-
Varjačić, Helena, Kiseljak, Dalibor, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., and Županić, M.
- Subjects
alpsko skijanje ,strah od kretanja ,koljeno ,prevencija - Abstract
Alpsko skijanje je jedan od najopasnijih zimskih sportova te nosi i veći broj ozljeda, najčešće koljena. Kineziofobija ili „strah od kretanja“ je stanje u kojem pojedinac doživljava strah od tjelesnog kretanja i aktivnosti kao rezultat osjećaja podložnosti ozljedi ili ponovnom ozljeđivanju. Sportska izvedba biva narušena stvaranjem kompenzatornih mehanizama kretanja koji tijelo i tjelesne segmente dovode u disbalans s potencijalom za povećano opterećenje i prenaprezanje struktura koje nisu bile ozljeđivane. Cilj istraživanja je ispitati razinu kineziofobije kod skijaša s ozljedama koljena. U istraživanju je sudjelovalo je 33 skijaša (22 ž i 11 m) u dobi od 18 do 53 godine, s prosjekom 24. Ispitanici se prosječno natjecateljskim skijanjem bave 14, 7 godina. U procjeni je korištena Tampa skala kineziofobije. Rezultati su pokazali da broj ozljeda koljena kod skijaša je najmanje 1 te najviše 11, u prosjeku 2, 45 ozljede. Najčešće ozljede koljena su ozljeda prednjeg križnog ligamenta i meniska. Nema značajnosti razlika između lijevog i desnog koljena ili obostrane ozljede. 45, 5% ispitanih se aktivno bavi skijanjem, a njih 54, 5% se više ne natječu. Dominantna disciplina u 66, 8% skijaša je slalom, slijedi veleslalom sa 24, 2%, supervelesalom, spust i kombinacija sa 3%. Prosjek na upitniku iznosi 36 bodova, što je blizu kritične granice od 37 bodova. 36% sudionika ima visoku razinu kinezofobije. Po općoj razini kineziofobije nisu otkrivene statistički značajne razlike ni po spolu, ni s obzirom na broj operacija, ni s obzirom na to je li ozljedom zahvaćeno jedno koljeno ili oba, niti bave li se još aktivno skijanjem ili ne. Istraživanje je pokazalo i da stariji skijaši imaju značajno manji strah od ponovne ozljede. Iz dobivenih rezultata zaključujemo da je broj ozljeda koljena u skijanju velik te na njega treba utjecati kroz prevenciju, a u okviru rehabilitacije sportašima je potrebno pružiti i psihološku podršku kako bi spriječili ili smanjili kineziofobiju te tako prevenirali ponovnu ili novu ozljedu.
- Published
- 2020
15. Prisutnost boli u bolesnika starije životne dobi na odjelu medicinske rehabilitacije u Specijalnoj bolnici za medicinsku rehabilitaciju Krapinske Toplice
- Author
-
Goluban, Martina, Hercigonja-Szekeres, Mira, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., and Županić, M
- Subjects
bol, starija životna dob ,eliminacija boli - Abstract
Cilj istraživanja bio je utvrditi prisutnost boli, načine njena rješavanja, utjecaj boli na samopercepciju zdravlja, kvalitete života, osjećaj zadovoljstva te informiranost bolesnika o postojanju ambulante za bol. Ispitanici su bili sve osobe starije životne dobi (stariji od 65 godina) čija se rehabilitacija provodila na odjelima za medicinsku rehabilitaciju bolesnika s reumatskim bolestima u Specijalnoj bolnici za medicinsku rehabilitaciju Krapinske Toplice
- Published
- 2020
16. Jednostavno o kompliciranom - kako radi imunosni sustav
- Author
-
Vidić, Milica, Kocijan, Ivna, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., and Županić, M.
- Subjects
imunosni sustav ,urođena imunost ,stečena imunost - Abstract
Imunosni sustav brani tijelo od invazije mikroorganizama, sprječava rast tumorskih stanica i uklanja strane antigene. Leukociti pritom luče molekule – citokine, poput interleukina kojima je glavna funkcija komunikacija između stanica, i interferona koji imaju protuvirusno, antiproliferativno i imunoregulacijsko djelovanje. Urođenu ili nespecifičnu imunost čine makrofagi, neutrofili, prirodnoubilačke stanice i sustav komplementa, a najvažniji mehanizam urođene imunosti je fagocitoza. Urođena imunost aktivira stečenu ili specifičnu imunost koju čine T i B limfociti. B limfociti luče antitijela i nositelji su humoralne imunosti, a T limfociti su nositelji stanične imunosti. Jedni i drugi stvaraju memorijske limfocite koji pri idućem susretu s antigenom reagiraju znatno brže i učinkovitije. Cijepljenje oponaša prirodan proces nastajanja imunosti za specifični antigen i tako štiti organizam od zaraznih bolesti. Kada imuni sustav počne napadati antigene vlastitog organizma, nastaju autoimune bolesti. Pretjerana reakcija imunog sustava je alergija. Nedostatna funkcija imunosnog sustava, odnosno neke njegove komponente, uzrok je imunodeficijencija. Ovaj rad donosi kratki pregled najvažnijih funkcija imunosnog sustava koje bi svaka medicinska sestra ili medicinski tehničar trebali znati.
- Published
- 2020
17. Zdravstvena informatika nije sposobnost rukovanja medicinskim uređajem?!
- Author
-
Johan Kotur, Željka, Hercigonja-Szekeres, Mira, Lučanin, D., Pavić, J., Bošnir, J., Feher Turković, L., Racz, A., Rađenović, O., Roić, G., Sajko, T., Sedić, B., Madžar, T., Jurak, I., Njegovan Zvonarević, T., and Županić, M.
- Subjects
zdravstvena informatika ,analiza ,nastava - Abstract
Na Zdravstvenom veleučilištu u Zagrebu akademske godine 2019/20. na Katedri za informatiku u zdravstvu na kolegijima iz zdravstvene informatike na prvoj godini preddiplomskih studija pokrenuto je pilot istraživanje o razumijevanju pojma „zdravstvena informatika“. U komunikaciji sa studentima prošlih godina uočeno je da im taj pojam nije u potpunosti razumljiv. Točnije, čini se da zdravstvena informatika studentima znači različito od uobičajenih definicija, a najčešće je dovode u vezu sa sposobnošću rukovanja medicinskim uređajima i programima na njima. Rezultati istraživanja primijenit će se za unapređenje teorijske i vježbovne nastave.
- Published
- 2020
18. Short-Term In Vitro Exposure of Human Blood to 5G Network Frequencies: Do Sex and Frequency Additionally Affect Erythrocyte Morphometry?
- Author
-
Žura N, Vince S, Perić P, Vilić M, Malarić K, Rimac V, Golubić Ćepulić B, Vajdić M, Jurak I, Milinković Tur S, Poljičak Milas N, Samardžija M, Nemir J, Telebuh M, and Žura Žaja I
- Abstract
Background/Objectives : This study assessed the effects of 5G radiofrequency electromagnetic radiation (RF-EMR) at different frequencies (700 MHz, 2500 MHz, 3500 MHz) on the complete blood count (CBC), erythrocyte morphometry, and platelet activation after the short-term in vitro exposure of human blood. Methods : Blood samples from 30 healthy volunteers (15 men and 15 women, aged 25-40 years old) were collected at three intervals (14 days apart). For each collection, four tubes of blood were drawn per volunteer-two experimental and two controls. Experimental samples were exposed to 5G RF-EMR for 2 h at room temperature using a half-cone gigahertz transverse electromagnetic cell. The CBC was analysed via a haematology analyser, the erythrocyte morphometry was analysed using the SFORM program, and platelet activation was analysed via flow cytometry. Results : The CBC and platelet activation showed no significant differences between the experimental and control samples. However, the erythrocyte morphometry exhibited notable changes. At 700 MHz, the erythrocyte size, contour, and membrane roughness increased significantly for both sexes, with women's cells showing greater sensitivity. At 2500 MHz, women exhibited an increased contour index and a decreased solidity and form factor. At 3500 MHz, women showed an increased contour index and outline but a decreased solidity, elongation, and form factor. Cluster analysis identified two erythrocyte subpopulations: smaller, rounder cells with smooth membranes and larger cells with rougher membranes. Conclusions : These results indicate that 5G RF-EMR exposure significantly alters erythrocyte morphometry. The strongest effects were observed at 700 MHz, where men exhibited greater membrane roughness, and women showed larger and rounder erythrocytes. These findings suggest that short-term in vitro 5G RF-EMR exposure disrupts the cytoskeleton, increasing membrane permeability and deformability.
- Published
- 2025
- Full Text
- View/download PDF
19. Evaluating the Efficacy of Capacitive Resistive Monopolar Radiofrequency Combined With Proprioceptive Neuromuscular Facilitation in Managing Chronic Low Back Pain: A Randomised Controlled Trial.
- Author
-
Jurak I, Grabar S, Žura N, and Jakuš L
- Subjects
- Humans, Female, Male, Single-Blind Method, Middle Aged, Adult, Combined Modality Therapy, Treatment Outcome, Chronic Pain therapy, Disability Evaluation, Proprioception physiology, Muscle Stretching Exercises, Muscle Strength physiology, Low Back Pain therapy, Pain Measurement
- Abstract
Background and Purpose: This randomised controlled trial evaluates the effectiveness of capacitive resistive monopolar radiofrequency (CRMRF) combined with proprioceptive neuromuscular facilitation (PNF) training in managing chronic low back pain (CLBP). Given the multifactorial nature of CLBP, this study explores a multimodal treatment approach integrating CRMRF, known for its thermal effects and ability to alleviate pain through improved cell metabolism and microcirculation, with PNF training, which enhances muscle strength, flexibility, and proprioception., Methods: This study was designed as a single-blind, parallel, randomised controlled trial conducted in an outpatient clinical setting. Over the course of four months, 62 participants, suffering from chronic low back pain were randomly assigned to receive either the combined CRMRF and PNF treatment or PNF alone, with primary outcomes measured in terms of pain and functional disability using the Visual Analogue Scale (VAS), Oswestry Disability Index (ODI). For secondary outcome of disability associated with pain, Quebec Pain Disability Scale (QPDS) and Roland-Morris Disability Questionnaire (RMDQ) were used. The study's hypothesis was that the combined treatment would reduce pain and disability more effectively than PNF alone., Results: Results indicated that the experimental group experienced greater improvements in pain and functional disability, surpassing the minimally clinically important difference (MCID) for the VAS, ODI, QPDS and RMDQ, suggesting the clinical relevance of the combined CRMRF and PNF approach., Discussion: These findings are consistent with previous research highlighting the benefits of CRMRF in various musculoskeletal disorders and suggest that integrating CRMRF with PNF training offers a promising non-invasive treatment option for CLBP sufferers. Overall, our study contributes to the growing evidence base supporting innovative, multimodal treatment strategies for managing CLBP, with the potential to enhance patients' quality of life., Trial Registration: ClinicalTrials.gov identifier: NCT05682287., (© 2024 The Author(s). Physiotherapy Research International published by John Wiley & Sons Ltd.)
- Published
- 2025
- Full Text
- View/download PDF
20. SERUM ACTIVITY OF ANTIOXIDATIVE ENZYMES AND CONCENTRATION OF MALONDIALDEHYDE AS PREDICTORS OF COLORECTAL CANCER STAGE IN CROATIAN PATIENTS.
- Author
-
Mojsović Ćuić A, Feher Turković L, Domjanić Drozdek S, Jurak I, Đikić D, Landeka Jurčević I, Skoko M, Rotim N, Vrdoljak DV, and Đaković N
- Subjects
- Humans, Male, Female, Middle Aged, Croatia epidemiology, Aged, Oxidative Stress, Antioxidants metabolism, Biomarkers, Tumor blood, Neoplasm Staging, Adult, Glutathione blood, Lipid Peroxidation, Colorectal Neoplasms blood, Colorectal Neoplasms pathology, Malondialdehyde blood, Catalase blood, Superoxide Dismutase blood
- Abstract
One of the factors involved in the colorectal cancer development is intracellular oxidative stress and antioxidative imbalance. The study aimed to explore the link between oxidative stress measured by the activity of antioxidative markers and lipid peroxidation product malondialdehyde (MDA) as possible cancer predictors of colorectal cancer by using several statistical methods. The study included 50 adult colorectal cancer patients of both genders. MDA level, the activity of antioxidative markers superoxide dismutase and catalase, and glutathione concentration were determined in patient sera. There was no age difference between male and female patients (p=0.579), and no gender differences according to cancer site (p=0.995), stage (p=0.083), and size (p=0.245). There were no differences in the levels of studied enzymes. Correlation analysis of antioxidative markers and MDA with cancer size and patient age revealed strongest individual correlation between the MDA and cancer size variables (r=-0.56)., (Sestre Milosrdnice University Hospital.)
- Published
- 2024
- Full Text
- View/download PDF
21. Clinical and Demographic Characteristics of Herpetic Keratitis Patients-Tertiary Centre Experience.
- Author
-
Grubešić P, Jurak I, Čaljkušić-Mance T, Belančić A, and Grubešić A
- Subjects
- Humans, Female, Male, Middle Aged, Aged, Prospective Studies, Adult, Visual Acuity, Aged, 80 and over, Recurrence, Tertiary Care Centers statistics & numerical data, Demography, Keratitis, Herpetic epidemiology, Keratitis, Herpetic diagnosis
- Abstract
Background and Objectives : Herpes simplex keratitis (HSK) is the leading infectious cause of corneal damage and associated loss of visual acuity. Because of its frequent recurrence, it represents a major health problem; thus, timely and accurate diagnosis is the key to successful treatment. To enable this, we aimed to determine HSK patients' demographic and clinical features. Materials and Methods : This prospective study included 55 patients diagnosed with HSK between March 2019 and August 2022 at the Department of Ophthalmology, Clinical Hospital Rijeka. Results : We found that HSK is most prevalent in the elderly, with 72.73% of patients older than 60. The most common HSK types were dendritic (HSK-D; 43.64%) and stromal with epithelial ulceration (HSK-SEU 23.64%). HSK recurrences occurred in 65.45% of patients, with most having two to five recurrences (55.56%). Visual acuity at presentation (65.5%) and after treatment (50.9%) was mostly in the 20/50 range. The longest period until the disease symptoms were resolved was in the group with stromal HSK without epithelial ulceration (HSK-SnEU), for which symptoms lasted more than 11 weeks in 87.5% of patients. The overall incidence of HSK-related complications was high (85.45%), with 76.4% of patients having corneal scarring. The average time from symptom to treatment was 15.78 days. Interestingly, we observed a strong seasonality in the incidence of HSK, which was most prevalent in the colder months, with 63.6% of cases occurring between October and March. Conclusions : To the best of our knowledge, this is the first prospective study in Croatia, and one of the few in Europe, to describe the demographic and clinical features of HSK patients. We found that HSK is most common in the elderly population, with its dendritic form as a clinical presentation. We have shown that HSK is prone to recurrence and secondary complications, with a worryingly long time between symptom and treatment, indicating the need for diagnostic testing in routine practice.
- Published
- 2024
- Full Text
- View/download PDF
22. Effects of Multidisciplinary Biopsychosocial Rehabilitation on Short-Term Pain and Disability in Chronic Low Back Pain: A Systematic Review with Network Meta-Analysis.
- Author
-
Jurak I, Delaš K, Erjavec L, Stare J, and Locatelli I
- Abstract
Chronic low back pain (CLBP) is a significant public health issue, with prevalence intensifying due to an ageing global population, amassing approximately 619 million cases in 2020 and projected to escalate to 843 million by 2050. In this study, we analyzed the effects of multidisciplinary biopsychosocial rehabilitation (MBR) on pain and disability. To address this question, we conducted a PRISMA-guided systematic review and random-effect network meta-analysis on studies collected from six electronic databases. The network comprised diverse MBR modalities (behavioral, educational, and work conditioning) alongside exercise therapy (ET), minimal intervention, and usual care, with pain and disability as outcomes. Ninety-three studies were included, encompassing a total of 8059 participants. The NMA substantiated that both ET and MBR modalities were effective in alleviating CLBP, with education-oriented MBR emerging as the most efficacious for pain mitigation (MD = 18.29; 95% CI = 13.70; 22.89) and behavior-focused MBR being the most efficacious for disability reduction (SMD = 0.88; 95% CI = 0.46; 1.30). Nevertheless, the discerned differences amongst the treatments were minimal and uncertain, highlighting that no modality was definitively superior to the others. Given the intricate nature of CLBP, embodying various facets, our findings advocate for a combined therapeutic approach to optimize treatment efficacy.
- Published
- 2023
- Full Text
- View/download PDF
23. HSV-1 miRNAs are post-transcriptionally edited in latently infected human ganglia.
- Author
-
Zubković A, Gomes C, Parchure A, Cesarec M, Ferenčić A, Rokić F, Jakovac H, Whitford AL, Dochnal SA, Cliffe AR, Cuculić D, Gallo A, Vugrek O, Hackenberg M, and Jurak I
- Subjects
- Humans, Virus Latency genetics, Viral Proteins metabolism, Ganglia metabolism, Trigeminal Ganglion, Virus Activation genetics, MicroRNAs genetics, MicroRNAs metabolism, Herpesvirus 1, Human physiology, Herpes Simplex
- Abstract
Importance: Herpes simplex virus 1 is an important human pathogen that has been intensively studied for many decades. Nevertheless, the molecular mechanisms regulating its establishment, maintenance, and reactivation from latency are poorly understood. Here, we show that HSV-1-encoded miR-H2 is post-transcriptionally edited in latently infected human tissues. Hyperediting of viral miRNAs increases the targeting potential of these miRNAs and may play an important role in regulating latency. We show that the edited miR-H2 can target ICP4, an essential viral protein. Interestingly, we found no evidence of hyperediting of its homolog, miR-H2, which is expressed by the closely related virus HSV-2. The discovery of post-translational modifications of viral miRNA in the latency phase suggests that these processes may also be important for other non-coding viral RNA in the latency phase, including the intron LAT, which in turn may be crucial for understanding the biology of this virus., Competing Interests: The authors declare no conflict of interest.
- Published
- 2023
- Full Text
- View/download PDF
24. Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders.
- Author
-
De Marchi F, Munitic I, Vidatic L, Papić E, Rački V, Nimac J, Jurak I, Novotni G, Rogelj B, Vuletic V, Liscic RM, Cannon JR, Buratti E, Mazzini L, and Hecimovic S
- Abstract
Many potential immune therapeutic targets are similarly affected in adult-onset neurodegenerative diseases, such as Alzheimer's (AD) disease, Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD), as well as in a seemingly distinct Niemann-Pick type C disease with primarily juvenile onset. This strongly argues for an overlap in pathogenic mechanisms. The commonly researched immune targets include various immune cell subsets, such as microglia, peripheral macrophages, and regulatory T cells (Tregs); the complement system; and other soluble factors. In this review, we compare these neurodegenerative diseases from a clinical point of view and highlight common pathways and mechanisms of protein aggregation, neurodegeneration, and/or neuroinflammation that could potentially lead to shared treatment strategies for overlapping immune dysfunctions in these diseases. These approaches include but are not limited to immunisation, complement cascade blockade, microbiome regulation, inhibition of signal transduction, Treg boosting, and stem cell transplantation.
- Published
- 2023
- Full Text
- View/download PDF
25. RNA Editing-Dependent and -Independent Roles of Adenosine Deaminases Acting on RNA Proteins in Herpesvirus Infection-Hints on Another Layer of Complexity.
- Author
-
Ivanišević V, Žilić L, Čunko M, Fadiga H, Munitić I, and Jurak I
- Subjects
- Humans, RNA Editing, RNA, Double-Stranded, Adenosine metabolism, Adenosine Deaminase metabolism, Herpesviridae Infections
- Abstract
The Adenosine Deaminases Acting on RNA (ADAR) catalyze the posttranscriptional deamination of adenosine residues to inosine in double-stranded RNAs (dsRNAs, A-to-I editing), preventing the overactivation of dsRNA sensor molecules and interferons. RNA editing is the cornerstone of innate immunity that distinguishes between self and non-self (virus), and it is essential for normal regulation of cellular homeostasis. Although much is already known about the role of ADAR proteins in RNA virus infection, the role of ADAR proteins in herpesvirus infection remains largely unexplored. In this review, we provide several lines of evidence from studies of different herpesviruses for another level of complexity in regulating the already intricate biphasic life cycle of herpesviruses.
- Published
- 2023
- Full Text
- View/download PDF
26. Photodynamic Inhibition of Herpes Simplex Virus 1 Infection by Tricationic Amphiphilic Porphyrin with a Long Alkyl Chain.
- Author
-
Jurak I, Cokarić Brdovčak M, Djaković L, Bertović I, Knežević K, Lončarić M, Jurak Begonja A, and Malatesti N
- Abstract
Photodynamic therapy (PDT) is broadly used to treat different tumors, and it is a rapidly developing approach to inactivating or inhibiting the replication of fungi, bacteria, and viruses. Herpes simplex virus 1 (HSV-1) is an important human pathogen and a frequently used model to study the effects of PDT on enveloped viruses. Although many photosensitizers (PSs) have been tested for their antiviral properties, analyses are usually limited to assessing the reduction in viral yield, and thus the molecular mechanisms of photodynamic inactivation (PDI) remain poorly understood. In this study, we investigated the antiviral properties of TMPyP3-C
17 H35 , a tricationic amphiphilic porphyrin-based PS with a long alkyl chain. We show that light-activated TMPyP3-C17 H35 can efficiently block virus replication at certain nM concentrations without exerting obvious cytotoxicity. Moreover, we show that the levels of viral proteins (immediate-early, early, and late genes) were greatly reduced in cells treated with subtoxic concentrations of TMPyP3-C17 H35 , resulting in markedly decreased viral replication. Interestingly, we observed a strong inhibitory effect of TMPyP3-C17 H35 on the virus yield only when cells were treated before or shortly after infection. In addition to the antiviral activity of the internalized compound, we show that the compound dramatically reduces the infectivity of free virus in the supernatant. Overall, our results demonstrate that activated TMPyP3-C17 H35 effectively inhibits HSV-1 replication and that it can be further developed as a potential novel treatment and used as a model to study photodynamic antimicrobial chemotherapy.- Published
- 2023
- Full Text
- View/download PDF
27. The Virus-Induced Upregulation of the miR-183/96/182 Cluster and the FoxO Family Protein Members Are Not Required for Efficient Replication of HSV-1.
- Author
-
Zubković A, Žarak I, Ratkaj I, Rokić F, Jekić M, Pribanić Matešić M, Lebrón R, Gómez-Martín C, Lisnić B, Lisnić VJ, Jonjić S, Pan D, Vugrek O, Hackenberg M, and Jurak I
- Subjects
- Humans, Up-Regulation, Virus Replication, Herpes Simplex genetics, Herpesvirus 1, Human physiology, MicroRNAs genetics, MicroRNAs metabolism
- Abstract
Herpes simplex virus 1 (HSV-1) expresses a large number of miRNAs, and their function is still not completely understood. In addition, HSV-1 has been found to deregulate host miRNAs, which adds to the complexity of the regulation of efficient virus replication. In this study, we comprehensively addressed the deregulation of host miRNAs by massive-parallel sequencing. We found that only miRNAs expressed from a single cluster, miR-183/96/182, are reproducibly deregulated during productive infection. These miRNAs are predicted to regulate a great number of potential targets involved in different cellular processes and have only 33 shared targets. Among these, members of the FoxO family of proteins were identified as potential targets for all three miRNAs. However, our study shows that the upregulated miRNAs do not affect the expression of FoxO proteins, moreover, these proteins were upregulated in HSV-1 infection. Furthermore, we show that the individual FoxO proteins are not required for efficient HSV-1 replication. Taken together, our results indicate a complex and redundant response of infected cells to the virus infection that is efficiently inhibited by the virus.
- Published
- 2022
- Full Text
- View/download PDF
28. Effects of Bobath treatment and specific mobilizations on gait in stroke patients: A randomized clinical trial.
- Author
-
Grozdek Čovčić G, Jurak I, Telebuh M, Maček Z, Bertić Ž, Žura N, Grubišić M, Matić H, Tišlar MH, and Jakuš L
- Subjects
- Gait, Humans, Postural Balance, Time and Motion Studies, Stroke complications, Stroke therapy, Stroke Rehabilitation
- Abstract
Background: After a stroke, patients experience sensorimotor damage, balance disorders, loss of selective movement, hypotonia and/or hypertonia, and hypersensitivity, all of which affect gait., Objective: The aim of the study was to establish the effectiveness of Bobath therapy with additional specific soft tissue mobilizations versus standard Bobath intervention., Methods: Subjects were randomly divided into two groups (S1 and S2) of 20 people each. Both groups underwent the same intervention (Bobath concept) over a 5-week period, while the second study group (S2) also received additional, specific soft tissue mobilization. The Berg Balance Scale (BBS), Timed Up and Go Test (TUGT), Active Range of Motion (AROM) of dorsiflexion and knee flexion and extension were used as clinical variables to assess the efficacy of therapy modalities. Data was analysed using a mixed model ANOVA., Results: A significant interaction of group and time was found. The experimental (S2) group had a larger improvement of balance and AROM than the control (S1) group. There was no clear advantage of one group over the other for TUGT., Conclusion: The findings demonstrate that a combination of Bobath treatment and additional specific soft tissue mobilizations are more effective in increasing AROM and balance and mobility.
- Published
- 2022
- Full Text
- View/download PDF
29. Decrease in handgrip strength in rheumatoid arthritis (RA): is there a sex-related difference?
- Author
-
Žura N, Vukorepa M, Jurak I, Perić P, Botonjić J, Matijević A, Mitrović HK, Žerjavić NL, Durmiš KK, Kalebota N, Žagar I, and Caktaš IL
- Subjects
- Adult, Aged, Case-Control Studies, Cross-Sectional Studies, Disease Progression, Female, Humans, Male, Middle Aged, Sex Factors, Arthritis, Rheumatoid physiopathology, Hand Strength
- Abstract
Rheumatoid arthritis occurs two to three times more often in women than in men and it has been less studied in men. The results of gender influence on clinical course of the disease are contradictory. The aim of this study is to determine the difference in handgrip strength between female and male RA patients in comparison to healthy individuals. The study included 100 RA patients and 100 healthy individuals (50% were male in both groups). Handgrip strength was measured in both hands using a dynamometer. A two-way ANCOVA was used to analyse the data and age was included in the study as covariate. The results show that both male and female RA patients have lower handgrip strength compared to healthy individuals. The analysis of gender and disease interaction has shown that male RA patients have lower handgrip strength than female RA patients in comparison with the healthy group, age adjusted. This interaction is evident and statistically significant in both right hand (F 1, 195) = 14.62; p < 0.01) and left hand (F 1, 195) = 20.54; p < 0.01). The common-language effect size has shown that there is 92% (right hand) and 93% (left hand) chance that male individual will have stronger handgrip than his female counterpart. In RA patients, there is 77% chance for both hands that male will have stronger handgrip. Men and women with RA have significantly lower handgrip strength compared to healthy individuals and the difference is more pronounced in men which was not previously observed in the literature., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2021
- Full Text
- View/download PDF
30. Diverse SARS-CoV-2 variants preceded the initial COVID-19 outbreak in Croatia.
- Author
-
Rokić F, Trgovec-Greif L, Sučić N, Čemeljić N, Grbeša ĐC, Svedružić Ž, Rukavina T, Vugrek O, and Jurak I
- Subjects
- Coronavirus 3C Proteases chemistry, Croatia epidemiology, Genome, Viral, Humans, Models, Molecular, Phylogeny, Protein Conformation, Whole Genome Sequencing, COVID-19 epidemiology, COVID-19 virology, Genetic Variation, SARS-CoV-2 genetics
- Abstract
We developed a next-generation SARS-CoV-2 sequencing platform and obtained the first SARS-CoV-2 sequences from patients in Croatia at the beginning of the COVID-19 outbreak in the spring of 2020. Integrating the sequencing and the epidemiological data, we show that patients were infected with different SARS-CoV-2 variants belonging to different clades (mostly G and GH). This result confirms that there was widespread virus transmission early in 2020. Interestingly, we identified a unique mutation resulting in a V13I substitution in Nsp5A, the main viral protease, in a patient who had not received antiviral therapy.
- Published
- 2021
- Full Text
- View/download PDF
31. Successful sequencing of the first SARS-CoV-2 genomes from Croatian patients.
- Author
-
Jurak I, Rukavina T, and Vugrek O
- Published
- 2020
32. The Influence of the Schoolbag on Standing Posture of First-Year Elementary School Students.
- Author
-
Jurak I, Rađenović O, Bolčević F, Bartolac A, and Medved V
- Subjects
- Child, Croatia, Female, Head, Humans, Male, Posture, Lifting adverse effects, Schools, Standing Position, Students
- Abstract
The purpose of this study was to determine the influence of the mass of a schoolbag on standing posture in first-year elementary school children. First-year elementary school students (n = 76) participated in this study. The data was digitized and analyzed using SkillSpector and Kinovea. Results have shown a change of Center of Gravity (COG) position in all three anatomical planes ( p < 0.01), as well as a change in two out of three measured postural angles-craniovertebral ( p < 0.01) and craniocervical ( p < 0.01) angle. The most important aspect of changed posture, anterior shift of COG, was measured to be 2.4 cm and was in moderate negative correlation with student body mass (-0.4, p < 0.01) and height (-0.4, p < 0.01) when students were encumbered with a schoolbag weighing 16.11% of their body mass, on the average. Also, this study confirms that when encumbered, students' head posture shifts to a more protracted position., Competing Interests: “The authors declare no conflict of interest.”
- Published
- 2019
- Full Text
- View/download PDF
33. sRNAbench and sRNAtoolbox 2019: intuitive fast small RNA profiling and differential expression.
- Author
-
Aparicio-Puerta E, Lebrón R, Rueda A, Gómez-Martín C, Giannoukakos S, Jaspez D, Medina JM, Zubkovic A, Jurak I, Fromm B, Marchal JA, Oliver J, and Hackenberg M
- Subjects
- Gene Expression Profiling, Genetic Variation, Sequence Analysis, RNA, MicroRNAs chemistry, MicroRNAs metabolism, Software
- Abstract
Since the original publication of sRNAtoolbox in 2015, small RNA research experienced notable advances in different directions. New protocols for small RNA sequencing have become available to address important issues such as adapter ligation bias, PCR amplification artefacts or to include internal controls such as spike-in sequences. New microRNA reference databases were developed with different foci, either prioritizing accuracy (low number of false positives) or completeness (low number of false negatives). Additionally, other small RNA molecules as well as microRNA sequence and length variants (isomiRs) have continued to gain importance. Finally, the number of microRNA sequencing studies deposited in GEO nearly triplicated from 2014 (280) to 2018 (764). These developments imply that fast and easy-to-use tools for expression profiling and subsequent downstream analysis of miRNA-seq data are essential to many researchers. Key features in this sRNAtoolbox release include addition of all major RNA library preparation protocols to sRNAbench and improvements in sRNAde, a tool that summarizes several aspects of small RNA sequencing studies including the detection of consensus differential expression. A special emphasis was put on the user-friendliness of the tools, for instance sRNAbench now supports parallel launching of several jobs to improve reproducibility and user time efficiency., (© The Author(s) 2019. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2019
- Full Text
- View/download PDF
34. Herpes Simplex Virus 1 Lytic Infection Blocks MicroRNA (miRNA) Biogenesis at the Stage of Nuclear Export of Pre-miRNAs.
- Author
-
Pan D, Li G, Morris-Love J, Qi S, Feng L, Mertens ME, Jurak I, Knipe DM, and Coen DM
- Subjects
- Animals, Blotting, Northern, Cell Line, Disease Models, Animal, Gene Expression Regulation, Herpes Simplex pathology, Humans, Immediate-Early Proteins genetics, Immediate-Early Proteins metabolism, Mice, Mutation, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism, Trigeminal Ganglion pathology, Trigeminal Ganglion virology, Viral Proteins genetics, Viral Proteins metabolism, Virus Latency, Active Transport, Cell Nucleus, Herpes Simplex virology, Herpesvirus 1, Human growth & development, Host-Pathogen Interactions, MicroRNAs metabolism, RNA Precursors metabolism
- Abstract
Herpes simplex virus 1 (HSV-1) switches between two infection programs, productive ("lytic") and latent infection. Some HSV-1 microRNAs (miRNAs) have been hypothesized to help control this switch, and yet little is known about regulation of their expression. Using Northern blot analyses, we found that, despite inherent differences in biogenesis efficiency among six HSV-1 miRNAs, all six exhibited high pre-miRNA/miRNA ratios during lytic infection of different cell lines and, when detectable, in acutely infected mouse trigeminal ganglia. In contrast, considerably lower ratios were observed in latently infected ganglia and in cells transduced with lentiviral vectors expressing the miRNAs, suggesting that HSV-1 lytic infection blocks miRNA biogenesis. This phenomenon is not specific to viral miRNAs, as a host miRNA expressed from recombinant HSV-1 also exhibited high pre-miRNA/miRNA ratios late during lytic infection. The levels of most of the mature miRNAs remained stable during infection in the presence of actinomycin D, indicating that the high ratios are due to inefficient pre-miRNA conversion to miRNA. Cellular fractionation experiments showed that late (but not early) during infection, pre-miRNAs were enriched in the nucleus and depleted in the cytoplasm, indicating that nuclear export was blocked. A mutation eliminating ICP27 expression or addition of acyclovir reduced pre-miRNA/miRNA ratios, but mutations drastically reducing Us11 expression did not. Thus, HSV-1 lytic infection inhibits miRNA biogenesis at the step of nuclear export and does so in an ICP27- and viral DNA synthesis-dependent manner. This mechanism may benefit the virus by reducing expression of repressive miRNAs during lytic infection while permitting elevated expression during latency. IMPORTANCE Various mechanisms have been identified by which viruses target host small RNA biogenesis pathways to achieve optimal infection outcomes. Herpes simplex virus 1 (HSV-1) is a ubiquitous human pathogen whose successful persistence in the host entails both productive ("lytic") and latent infection. Although many HSV-1 miRNAs have been discovered and some are thought to help control the lytic/latent switch, little is known about regulation of their biogenesis. By characterizing expression of both pre-miRNAs and mature miRNAs under various conditions, this study revealed striking differences in miRNA biogenesis between lytic and latent infection and uncovered a regulatory mechanism that blocks pre-miRNA nuclear export and is dependent on viral protein ICP27 and viral DNA synthesis. This mechanism represents a new virus-host interaction that could limit the repressive effects of HSV-1 miRNAs hypothesized to promote latency and may shed light on the regulation of miRNA nuclear export, which has been relatively unexplored., (Copyright © 2019 Pan et al.)
- Published
- 2019
- Full Text
- View/download PDF
35. Herpes Simplex Virus 1 Deregulation of Host MicroRNAs.
- Author
-
Cokarić Brdovčak M, Zubković A, and Jurak I
- Abstract
Viruses utilize microRNAs (miRNAs) in a vast variety of possible interactions and mechanisms, apparently far beyond the classical understanding of gene repression in humans. Likewise, herpes simplex virus 1 (HSV-1) expresses numerous miRNAs and deregulates the expression of host miRNAs. Several HSV-1 miRNAs are abundantly expressed in latency, some of which are encoded antisense to transcripts of important productive infection genes, indicating their roles in repressing the productive cycle and/or in maintenance/reactivation from latency. In addition, HSV-1 also exploits host miRNAs to advance its replication or repress its genes to facilitate latency. Here, we discuss what is known about the functional interplay between HSV-1 and the host miRNA machinery, potential targets, and the molecular mechanisms leading to an efficient virus replication and spread.
- Published
- 2018
- Full Text
- View/download PDF
36. Herpes simplex virus 1 miRNA sequence variations in latently infected human trigeminal ganglia.
- Author
-
Cokarić Brdovčak M, Zubković A, Ferenčić A, Šoša I, Stemberga V, Cuculić D, Rokić F, Vugrek O, Hackenberg M, and Jurak I
- Subjects
- Herpesvirus 3, Human genetics, Humans, Sequence Analysis, DNA, Genetic Variation, Herpes Simplex virology, Herpesvirus 1, Human genetics, MicroRNAs genetics, RNA, Viral genetics, Trigeminal Ganglion virology, Virus Latency
- Abstract
Human herpes simplex virus 1 (HSV-1) expresses numerous miRNAs, the function of which is not well understood. Several qualitative and quantitative analyses of HSV-1 miRNAs have been performed on infected cells in culture and animal models, however, there is very limited knowledge of their expression in human samples. We sequenced small-RNA libraries of RNA derived from human trigeminal ganglia latently infected with HSV-1 and Varicella zoster virus (VZV) and detected only a small subset of HSV-1 miRNA. The most abundantly expressed miRNAs are miR-H2, miRNA that regulates the expression of immediate early gene ICP0, and miR-H3 and -H4, both miRNAs expressed antisense to the transcript encoding the major neurovirulence factor ICP34.5. The sequence of many HSV-1 miRNAs detected in human samples was different from the sequences deposited in miRBase, which might significantly affect targeted functional analyses., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
37. Viral Ubiquitin Ligase Stimulates Selective Host MicroRNA Expression by Targeting ZEB Transcriptional Repressors.
- Author
-
Lutz G, Jurak I, Kim ET, Kim JY, Hackenberg M, Leader A, Stoller ML, Fekete DM, Weitzman MD, Coen DM, and Wilson AC
- Subjects
- Cell Nucleus, Cells, Cultured, Fibroblasts virology, Gene Expression Regulation, Herpesvirus 1, Human genetics, Humans, Immediate-Early Proteins deficiency, Immediate-Early Proteins genetics, Nerve Tissue Proteins genetics, Neurons virology, Protein Binding, Proteolysis, RNA-Binding Proteins genetics, Ubiquitin-Protein Ligases deficiency, Ubiquitin-Protein Ligases genetics, Virus Replication, Zinc Finger E-box-Binding Homeobox 1 genetics, Herpesvirus 1, Human enzymology, Host-Pathogen Interactions, MicroRNAs genetics, Ubiquitin-Protein Ligases metabolism, Zinc Finger E-box-Binding Homeobox 1 metabolism
- Abstract
Infection with herpes simplex virus-1 (HSV-1) brings numerous changes in cellular gene expression. Levels of most host mRNAs are reduced, limiting synthesis of host proteins, especially those involved in antiviral defenses. The impact of HSV-1 on host microRNAs (miRNAs), an extensive network of short non-coding RNAs that regulate mRNA stability/translation, remains largely unexplored. Here we show that transcription of the miR-183 cluster (miR-183, miR-96, and miR-182) is selectively induced by HSV-1 during productive infection of primary fibroblasts and neurons. ICP0, a viral E3 ubiquitin ligase expressed as an immediate-early protein, is both necessary and sufficient for this induction. Nuclear exclusion of ICP0 or removal of the RING (really interesting new gene) finger domain that is required for E3 ligase activity prevents induction. ICP0 promotes the degradation of numerous host proteins and for the most part, the downstream consequences are unknown. Induction of the miR-183 cluster can be mimicked by depletion of host transcriptional repressors zinc finger E-box binding homeobox 1 (ZEB1)/-crystallin enhancer binding factor 1 (δEF1) and zinc finger E-box binding homeobox 2 (ZEB2)/Smad-interacting protein 1 (SIP1), which we establish as new substrates for ICP0-mediated degradation. Thus, HSV-1 selectively stimulates expression of the miR-183 cluster by ICP0-mediated degradation of ZEB transcriptional repressors., Competing Interests: The authors declare no conflict of interest. The funding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
- Published
- 2017
- Full Text
- View/download PDF
38. Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents.
- Author
-
Malatesti N, Munitic I, and Jurak I
- Abstract
Photodynamic therapy (PDT) combines a photosensitiser, light and molecular oxygen to induce oxidative stress that can be used to kill pathogens, cancer cells and other highly proliferative cells. There is a growing number of clinically approved photosensitisers and applications of PDT, whose main advantages include the possibility of selective targeting, localised action and stimulation of the immune responses. Further improvements and broader use of PDT could be accomplished by designing new photosensitisers with increased selectivity and bioavailability. Porphyrin-based photosensitisers with amphiphilic properties, bearing one or more positive charges, are an effective tool in PDT against cancers, microbial infections and, most recently, autoimmune skin disorders. The aim of the review is to present some of the recent examples of the applications and research that employ this specific group of photosensitisers. Furthermore, we will highlight the link between their structural characteristics and PDT efficiency, which will be helpful as guidelines for rational design and evaluation of new PSs.
- Published
- 2017
- Full Text
- View/download PDF
39. Expression of herpes simplex virus 1 microRNAs in cell culture models of quiescent and latent infection.
- Author
-
Jurak I, Hackenberg M, Kim JY, Pesola JM, Everett RD, Preston CM, Wilson AC, and Coen DM
- Subjects
- Animals, Cell Culture Techniques, Fibroblasts metabolism, Herpes Simplex genetics, Herpesvirus 1, Human metabolism, High-Throughput Nucleotide Sequencing, Humans, Mice, Neurons metabolism, Rats, Herpes Simplex metabolism, Herpesvirus 1, Human genetics, MicroRNAs metabolism, Virus Latency genetics
- Abstract
To facilitate studies of herpes simplex virus 1 latency, cell culture models of quiescent or latent infection have been developed. Using deep sequencing, we analyzed the expression of viral microRNAs (miRNAs) in two models employing human fibroblasts and one using rat neurons. In all cases, the expression patterns differed from that in productively infected cells, with the rat neuron pattern most closely resembling that found in latently infected human or mouse ganglia in vivo.
- Published
- 2014
- Full Text
- View/download PDF
40. Herpes simplex virus is equipped with RNA- and protein-based mechanisms to repress expression of ATRX, an effector of intrinsic immunity.
- Author
-
Jurak I, Silverstein LB, Sharma M, and Coen DM
- Subjects
- 3' Untranslated Regions, Animals, Base Sequence, Cell Line, Chlorocebus aethiops, DNA Helicases genetics, DNA Helicases immunology, Down Syndrome, HEK293 Cells, Herpesvirus 1, Human genetics, Herpesvirus 1, Human immunology, Herpesvirus 1, Human pathogenicity, Herpesvirus 1, Human physiology, Herpesvirus 2, Human genetics, Herpesvirus 2, Human immunology, Herpesvirus 2, Human pathogenicity, Herpesvirus 2, Human physiology, Host-Pathogen Interactions genetics, Host-Pathogen Interactions immunology, Host-Pathogen Interactions physiology, Humans, Immediate-Early Proteins metabolism, MicroRNAs genetics, MicroRNAs immunology, MicroRNAs physiology, Nuclear Proteins genetics, Nuclear Proteins immunology, RNA, Messenger genetics, RNA, Messenger metabolism, RNA, Viral genetics, RNA, Viral immunology, RNA, Viral physiology, Repressor Proteins genetics, Repressor Proteins immunology, Repressor Proteins physiology, Simplexvirus genetics, Simplexvirus physiology, Transfection, Ubiquitin-Protein Ligases metabolism, Vero Cells, Viral Proteins genetics, Viral Proteins immunology, Viral Proteins physiology, X-linked Nuclear Protein, DNA Helicases antagonists & inhibitors, Nuclear Proteins antagonists & inhibitors, Simplexvirus immunology, Simplexvirus pathogenicity
- Abstract
Intrinsic immunity is a first-line intracellular defense against virus infection, and viruses have evolved mechanisms to counteract it. During herpes simplex virus (HSV) infection, nuclear domain 10 (ND10) components localize adjacent to incoming viral genomes and generate a repressive environment for viral gene expression. Here, we found that the ND10 component, alpha-thalassemia/mental retardation syndrome X-linked (ATRX) protein, is predicted to be a target of HSV-1 miR-H1 and HSV-2 miR-H6. These microRNAs (miRNAs) share a seed sequence and are abundant during lytic infection. Mimics of both miRNAs could deplete endogenous ATRX, and an miR-H1 mimic could repress the expression of a reporter linked to the 3' untranslated region of ATRX mRNA, identifying a cellular mRNA targeted by an HSV miRNA. Interestingly, ATRX protein and its mRNA were depleted in cells lytically infected with HSV, and ATRX protein was also depleted in cells infected with human cytomegalovirus. However, infection with an HSV-1 mutant lacking miR-H1 still resulted in ATRX depletion. This depletion was sensitive to a proteasome inhibitor and was largely ablated by a deletion of the gene encoding the immediate-early ICP0 protein. Additionally, a deletion of the gene encoding the tegument protein Vhs ablated most of the depletion of ATRX mRNA. Thus, HSV is equipped with multiple mechanisms to limit the expression of ATRX. As ATRX is implicated in repression of lytic viral gene expression, our results suggest roles for these different mechanisms during various phases of HSV infection.
- Published
- 2012
- Full Text
- View/download PDF
41. Mammalian alphaherpesvirus miRNAs.
- Author
-
Jurak I, Griffiths A, and Coen DM
- Subjects
- Animals, Gene Expression Regulation, Viral, Genome, Viral, Herpesvirus 1, Human genetics, Herpesvirus 2, Human genetics, Herpesvirus 3, Human genetics, Humans, MicroRNAs genetics, Virus Latency genetics, Alphaherpesvirinae genetics, MicroRNAs metabolism
- Abstract
Mammalian alphaherpesviruses are major causes of human and veterinary disease. During productive infection, these viruses exhibit complex and robust patterns of gene expression. These viruses also form latent infections in neurons of sensory ganglia in which productive cycle gene expression is highly repressed. Both modes of infection provide advantageous opportunities for regulation by microRNAs. Thus far, published data regarding microRNAs are available for six mammalian alphaherpesviruses. No microRNAs have yet been detected from varicella zoster virus. The five other viruses-herpes simplex viruses-1 and -2, herpes B virus, bovine herpesvirus-1, and pseudorabies virus-representing both genera of mammalian alphaherpesviruses have been shown to express microRNAs. In this article, we discuss these microRNAs in terms of where they are encoded in the viral genome relative to other viral transcripts; whether they are expressed during productive or latent infection; their potential targets; what little is known about their actual targets and functions during viral infection; and what little is known about the interactions of these viruses with the host microRNA machinery. This article is part of a Special Issue entitled: "MicroRNAs in viral gene regulation"., (Copyright © 2011. Published by Elsevier B.V.)
- Published
- 2011
- Full Text
- View/download PDF
42. Herpes simplex virus 1 microRNAs expressed abundantly during latent infection are not essential for latency in mouse trigeminal ganglia.
- Author
-
Kramer MF, Jurak I, Pesola JM, Boissel S, Knipe DM, and Coen DM
- Subjects
- Animals, Carrier State virology, Disease Models, Animal, Herpes Simplex virology, Herpesvirus 1, Human genetics, Male, Mice, MicroRNAs genetics, Sequence Deletion, Gene Expression Regulation, Viral, Herpesvirus 1, Human pathogenicity, MicroRNAs biosynthesis, Trigeminal Ganglion virology, Virus Latency
- Abstract
Several herpes simplex virus 1 microRNAs are encoded within or near the latency associated transcript (LAT) locus, and are expressed abundantly during latency. Some of these microRNAs can repress the expression of important viral proteins and are hypothesized to play important roles in establishing and/or maintaining latent infections. We found that in lytically infected cells and in acutely infected mouse ganglia, expression of LAT-encoded microRNAs was weak and unaffected by a deletion that includes the LAT promoter. In mouse ganglia latently infected with wild type virus, the microRNAs accumulated to high levels, but deletions of the LAT promoter markedly reduced expression of LAT-encoded microRNAs and also miR-H6, which is encoded upstream of LAT and can repress expression of ICP4. Because these LAT deletion mutants establish and maintain latent infections, these microRNAs are not essential for latency, at least in mouse trigeminal ganglia, but may help promote it., (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
43. Mutations in the M112/M113-coding region facilitate murine cytomegalovirus replication in human cells.
- Author
-
Schumacher U, Handke W, Jurak I, and Brune W
- Subjects
- Animals, Cell Survival, Cells, Cultured, DNA Mutational Analysis, DNA, Viral chemistry, DNA, Viral genetics, Humans, Mice, Sequence Analysis, DNA, Viral Load, Antigens, Viral genetics, Immediate-Early Proteins genetics, Muromegalovirus genetics, Muromegalovirus growth & development, Mutation, Missense, Virus Replication
- Abstract
Cytomegaloviruses, representatives of the Betaherpesvirinae, cause opportunistic infections in immunocompromised hosts. They infect various cells and tissues in their natural host but are highly species specific. For instance, human cytomegalovirus (HCMV) does not replicate in mouse cells, and human cells are not permissive for murine cytomegalovirus (MCMV) infection. However, the underlying molecular mechanisms are so far poorly understood. In the present study we isolated and characterized a spontaneously occurring MCMV mutant that has gained the capacity to replicate rapidly and to high titers in human cells. Compared to the parental wild-type (wt) virus, this mutant formed larger nuclear replication compartments and replicated viral DNA more efficiently. It also disrupted promyelocytic leukemia (PML) protein nuclear domains with greater efficiency but caused less apoptosis than did wt MCMV. Sequence analysis of the mutant virus genome revealed mutations in the M112/M113-coding region. This region is homologous to the HCMV UL112-113 region and encodes the viral early 1 (E1) proteins, which are known to play an important role in viral DNA replication. By introducing the M112/M113 mutations into wt MCMV, we demonstrated that they are sufficient to facilitate MCMV replication in human cells and are, at least in part, responsible for the efficient replication capability of the spontaneously adapted virus. However, additional mutations probably contribute as well. These results reveal a previously unrecognized role of the viral E1 proteins in regulating viral replication in different cells and provide new insights into the mechanisms of the species specificity of cytomegaloviruses.
- Published
- 2010
- Full Text
- View/download PDF
44. Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2.
- Author
-
Jurak I, Kramer MF, Mellor JC, van Lint AL, Roth FP, Knipe DM, and Coen DM
- Subjects
- Animals, Cell Line, Chlorocebus aethiops, Humans, MicroRNAs genetics, RNA, Viral genetics, Sequence Analysis, DNA, Conserved Sequence, Herpesvirus 1, Human physiology, Herpesvirus 2, Human physiology, MicroRNAs biosynthesis, Polymorphism, Genetic, RNA, Viral biosynthesis
- Abstract
Certain viruses use microRNAs (miRNAs) to regulate the expression of their own genes, host genes, or both. Previous studies have identified a limited number of miRNAs expressed by herpes simplex viruses 1 and 2 (HSV-1 and -2), some of which are conserved between these two viruses. To more comprehensively analyze the miRNAs expressed by HSV-1 or HSV-2 during productive and latent infection, we applied a massively parallel sequencing approach. We were able to identify 16 and 17 miRNAs expressed by HSV-1 and HSV-2, respectively, including all previously known species, and a number of previously unidentified virus-encoded miRNAs. The genomic positions of most miRNAs encoded by these two viruses are within or proximal to the latency-associated transcript region. Nine miRNAs are conserved in position and/or sequence, particularly in the seed region, between these two viruses. Interestingly, we did not detect an HSV-2 miRNA homolog of HSV-1 miR-H1, which is highly expressed during productive infection, but we did detect abundant expression of miR-H6, whose seed region is conserved with HSV-1 miR-H1 and might represent a functional analog. We also identified a highly conserved miRNA family arising from the viral origins of replication. In addition, we detected several pairs of complementary miRNAs and we found miRNA-offset RNAs (moRs) arising from the precursors of HSV-1 and HSV-2 miR-H6 and HSV-2 miR-H4. Our results reveal elements of miRNA conservation and divergence that should aid in identifying miRNA functions.
- Published
- 2010
- Full Text
- View/download PDF
45. Human papillomavirus 16 E7 inactivator of retinoblastoma family proteins complements human cytomegalovirus lacking UL97 protein kinase.
- Author
-
Kamil JP, Hume AJ, Jurak I, Münger K, Kalejta RF, and Coen DM
- Subjects
- DNA, Viral biosynthesis, Genes, Viral, Humans, Papillomavirus E7 Proteins, Phosphorylation, Phosphotransferases (Alcohol Group Acceptor) metabolism, Retinoblastoma Protein antagonists & inhibitors, Virus Replication, Oncogene Proteins, Viral metabolism, Phosphotransferases (Alcohol Group Acceptor) genetics, Retinoblastoma Protein metabolism
- Abstract
Several different families of DNA viruses encode proteins that inactivate the cellular retinoblastoma tumor suppressor protein (pRb), which normally functions to bind E2F transcription factors and restrict expression of genes necessary for cellular processes including DNA replication. Human cytomegalovirus (HCMV) UL97, a protein kinase functionally orthologous to cellular cyclin-dependent kinases, phosphorylates pRb on inactivating residues during HCMV infection. To assess if such phosphorylation is biologically relevant, we tested whether the human papillomavirus type 16 E7 protein, which inactivates pRb family proteins by direct binding and destabilization, could substitute for UL97 during HCMV infection. In the absence of UL97, expression of wild-type E7 protein, but not a mutant E7 unable to bind pRb family proteins, restored E2F-responsive cellular gene expression, late viral gene expression, and viral DNA synthesis to levels normally observed during wild-type virus infection of quiescent cells. UL97-null mutants exhibited more pronounced defects in virus production and DNA synthesis in quiescent cells as compared to serum-fed, cycling cells. E7 expression substantially enhanced infectious virus production in quiescent cells, but did not complement the defects observed during UL97-null virus infection of cycling cells. Thus, a primary role of UL97 is to inactivate pRb family proteins during infection of quiescent cells, and this inactivation likely abets virus replication by induction of cellular E2F-responsive genes. Our findings have implications for human cytomegalovirus disease and for drugs that target UL97.
- Published
- 2009
- Full Text
- View/download PDF
46. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.
- Author
-
Umbach JL, Kramer MF, Jurak I, Karnowski HW, Coen DM, and Cullen BR
- Subjects
- Animals, Base Sequence, Cell Line, Down-Regulation, Genome, Viral genetics, Herpesvirus 1, Human physiology, Humans, Immediate-Early Proteins biosynthesis, Immediate-Early Proteins genetics, Male, Mice, RNA Processing, Post-Transcriptional, RNA, Messenger genetics, RNA, Messenger metabolism, Ubiquitin-Protein Ligases biosynthesis, Ubiquitin-Protein Ligases genetics, Virus Latency physiology, Gene Expression Regulation, Viral, Herpesvirus 1, Human genetics, MicroRNAs genetics, MicroRNAs metabolism, RNA, Viral genetics, RNA, Viral metabolism, Virus Latency genetics
- Abstract
Herpesviruses are characterized by their ability to maintain life-long latent infections in their animal hosts. However, the mechanisms that allow establishment and maintenance of the latent state remain poorly understood. Herpes simplex virus 1 (HSV-1) establishes latency in neurons of sensory ganglia, where the only abundant viral gene product is a non-coding RNA, the latency associated transcript (LAT). Here we show that LAT functions as a primary microRNA (miRNA) precursor that encodes four distinct miRNAs in HSV-1 infected cells. One of these miRNAs, miR-H2-3p, is transcribed in an antisense orientation to ICP0-a viral immediate-early transcriptional activator that is important for productive HSV-1 replication and thought to have a role in reactivation from latency. We show that miR-H2-3p is able to reduce ICP0 protein expression, but does not significantly affect ICP0 messenger RNA levels. We also identified a fifth HSV-1 miRNA in latently infected trigeminal ganglia, miR-H6, which derives from a previously unknown transcript distinct from LAT. miR-H6 shows extended seed complementarity to the mRNA encoding a second HSV-1 transcription factor, ICP4, and inhibits expression of ICP4, which is required for expression of most HSV-1 genes during productive infection. These results may explain the reported ability of LAT to promote latency. Thus, HSV-1 expresses at least two primary miRNA precursors in latently infected neurons that may facilitate the establishment and maintenance of viral latency by post-transcriptionally regulating viral gene expression.
- Published
- 2008
- Full Text
- View/download PDF
47. Murine cytomegalovirus m38.5 protein inhibits Bax-mediated cell death.
- Author
-
Jurak I, Schumacher U, Simic H, Voigt S, and Brune W
- Subjects
- Animals, Cell Line, Cysteine Proteinase Inhibitors, DNA Fragmentation, DNA, Viral genetics, Fibroblasts virology, Gene Deletion, Genetic Complementation Test, Leupeptins pharmacology, Mice, Molecular Sequence Data, Muromegalovirus genetics, Muromegalovirus physiology, Protein Binding, Sequence Analysis, DNA, Staurosporine pharmacology, Viral Proteins genetics, bcl-2-Associated X Protein antagonists & inhibitors, Cell Death, Muromegalovirus immunology, Viral Proteins metabolism, bcl-2-Associated X Protein metabolism
- Abstract
Many viruses encode proteins that inhibit the induction of programmed cell death at the mitochondrial checkpoint. Murine cytomegalovirus (MCMV) encodes the m38.5 protein, which localizes to mitochondria and protects human HeLa cells and fibroblasts from apoptosis triggered by proteasome inhibitors but not from Fas-induced apoptosis. However, the ability of this protein to suppress the apoptosis of murine cells and its role during MCMV infection have not been investigated previously. Here we show that m38.5 is expressed at early time points during MCMV infection. Cells infected with MCMVs lacking m38.5 showed increased sensitivity to cell death induced by staurosporine, MG132, or the viral infection itself compared to the sensitivity of cells infected with wild-type MCMV. This defect was eliminated when an m38.5 or Bcl-X(L) gene was inserted into the genome of a deletion mutant. Using fibroblasts deficient in the proapoptotic Bcl-2 family proteins Bak and/or Bax, we further demonstrated that m38.5 protected from Bax- but not Bak-mediated apoptosis and interacted with Bax in infected cells. These results consolidate the role of m38.5 as a viral mitochondrion-localized inhibitor of apoptosis and its functional similarity to the human cytomegalovirus UL37x1 gene product. Although the m38.5 gene is not homologous to the UL37x1 gene at the sequence level, m38.5 is conserved among rodent cytomegaloviruses. Moreover, the fact that MCMV-infected cells are protected from both Bak- and Bax-mediated cell death suggests that MCMV possesses an additional, as-yet-unidentified mechanism to block Bak-mediated apoptosis.
- Published
- 2008
- Full Text
- View/download PDF
48. A single mutation at Tyr143 of human S-adenosylhomocysteine hydrolase renders the enzyme thermosensitive and affects the oxidation state of bound cofactor nicotinamide-adenine dinucleotide.
- Author
-
Beluzić R, Cuk M, Pavkov T, Fumić K, Barić I, Mudd SH, Jurak I, and Vugrek O
- Subjects
- Adenosylhomocysteinase chemistry, Amino Acid Substitution, Catalysis, Cysteine genetics, Cysteine metabolism, Dithiothreitol pharmacology, Enzyme Stability, Escherichia coli genetics, Hot Temperature, Humans, Hydrogen Bonding, Hydrolysis, Kinetics, Models, Molecular, Mutagenesis, Site-Directed, NAD chemistry, Oxidation-Reduction, Protein Folding, Protein Structure, Quaternary, Recombinant Proteins chemistry, Recombinant Proteins genetics, Recombinant Proteins metabolism, Reducing Agents pharmacology, Structure-Activity Relationship, Tyrosine genetics, Tyrosine metabolism, Adenosylhomocysteinase genetics, Adenosylhomocysteinase metabolism, Mutation, NAD metabolism
- Abstract
Recently, we have described the first human case of AdoHcyase (S-adenosylhomocysteine hydrolase) deficiency. Two point mutations in the AdoHcyase gene, the missense mutation p.Y143C (AdoHcyase in which Tyr143 is replaced by cysteine) and the truncation mutation p.W112stop (AdoHcyase in which Trp112 is replaced by opal stop codon) were identified [Barić, Fumić, Glenn, Cuk, Schulze, Finkelstein, James, Mejaski-Bosnjak, Pazanin, Pogribny et al. (2004) Proc. Natl. Acad. Sci. U.S.A. 101, 4234-4239]. To elucidate the molecular and catalytic properties of AdoHcyase, we have made recombinant wild-type and mutant p.Y143C (AdoHcyase in which Tyr143 is replaced by cysteine) enzymes for a comparative analysis. The catalytic rates of p.Y143C protein in the directions of S-adenosylhomocysteine synthesis or hydrolysis are decreased from 65% to 75%. Further, the oxidation states of coenzyme NAD differ between mutant and wild-type protein, with an increased NADH accumulation in the mutant p.Y143C enzyme of 88% NADH (wild-type contains 18% NADH). Quantitative binding of NAD is not affected. Native polyacrylamide gel electrophoresis showed, that mutant p.Y143C subunits are able to form the tetrameric complex as is the wild-type enzyme. CD analysis showed that the p.Y143C mutation renders the recombinant protein thermosensitive, with an unfolding temperature significantly reduced by 7 degrees C compared with wild-type protein. Change of Glu115 to lysine in wild-type protein causes a change in thermosensitivity almost identical with that found in the p.Y143C enzyme, indicating that the thermosensitivity is due to a missing hydrogen bond between Tyr143 and Glu115. We emphasize involvement of this particular hydrogen bond for subunit folding and/or holoenyzme stability. In summary, a single mutation in the AdoHcyase affecting both the oxidation state of bound co-factor NAD and enzyme stability is present in a human with AdoHcyase deficiency.
- Published
- 2006
- Full Text
- View/download PDF
49. Induction of apoptosis limits cytomegalovirus cross-species infection.
- Author
-
Jurak I and Brune W
- Subjects
- Animals, Caspase 9, Caspases metabolism, Cell Line, Enzyme Activation, Gene Expression Regulation, Viral, Humans, Mice, Proto-Oncogene Proteins c-bcl-2 genetics, Proto-Oncogene Proteins c-bcl-2 metabolism, Rats, Viral Proteins genetics, Viral Proteins metabolism, Zoonoses, Apoptosis physiology, Cytomegalovirus Infections, Muromegalovirus genetics, Muromegalovirus metabolism, Muromegalovirus pathogenicity, Species Specificity, Virus Replication physiology
- Abstract
Cross-species infections are responsible for the majority of emerging and re-emerging viral diseases. However, little is known about the mechanisms that restrict viruses to a certain host species, and the factors viruses need to cross the species barrier and replicate in a different host. Cytomegaloviruses (CMVs) are representatives of the beta-herpesviruses that are highly species specific. They replicate only in cells of their own or a closely related species. In this study, the molecular mechanism underlying the cytomegalovirus species specificity was investigated. We show that infection of human cells with the murine cytomegalovirus (MCMV) triggers the intrinsic apoptosis pathway involving caspase-9 activation. MCMV can break the species barrier and replicate in human cells if apoptosis is blocked by Bcl-2 or a functionally analogous protein. A single gene of the human cytomegalovirus encoding a mitochondrial inhibitor of apoptosis is sufficient to allow MCMV replication in human cells. Moreover, the same principle facilitates replication of the rat cytomegalovirus in human cells. Thus, induction of apoptosis serves as an innate immune defense to inhibit cross-species infections of rodent CMVs.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.